fluorodeoxyglucose f18 has been researched along with Thyroid Neoplasms in 774 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (0.26) | 18.7374 |
1990's | 49 (6.33) | 18.2507 |
2000's | 266 (34.37) | 29.6817 |
2010's | 384 (49.61) | 24.3611 |
2020's | 73 (9.43) | 2.80 |
Authors | Studies |
---|---|
Cheng, N; Ferri, V; Khan, S; Kuo, C; Noel, JE; Pratx, G; Shin, JH; Sunwoo, JB | 1 |
Gantumur, D; Kamioka, H; Li, Y; Mizoi, K; Ogihara, T; Tsushima, Y; Zhang, X; Zhu, M | 1 |
Brouwers, AH; de Leijer, JF; Kruijff, S; Links, TP; Metman, MJH; van der Hoorn, A; van Hemel, BM; Westerlaan, HE | 1 |
Jiang, L; Liu, B; Wang, Y; Xu, Y; Zhang, X | 1 |
Rao, Z; Wu, J; Zhang, C | 1 |
Chan, YC; Chen, CL; Chi, SY; Chou, FF; Lin, CC; Wu, YJ; Yong, CC | 1 |
Baudin, E; Chevalier, B; Deschamps, F; Djennaoui, M; Do Cao, C; Hadoux, J; Jannin, A; Lamartina, L; Leboulleux, S; Lion, G; Moutarde, C; Schlumberger, M; Vantyghem, MC | 1 |
Bal, C; Chakraborty, D; Khan, D | 1 |
Jie, X; Shi, H; Xiu, Y; Xu, A | 1 |
Cadili, L; Nabata, K; Pajak, C; Wiseman, SM | 1 |
Hod, N; Lantsberg, S; Levin, D | 1 |
Borel Rinkes, IHM; Braat, AJAT; de Keizer, B; de Vries, LH; Lebbink, CA; Lodewijk, L; Valk, GD; van Leeuwaarde, RS; van Santen, HM; van Treijen, MJC; Vriens, MR | 1 |
Bockisch, A; Brandenburg, T; Dralle, H; Fendler, WP; Führer-Sakel, D; Grafe, H; Grünwald, F; Herrmann, K; Jentzen, W; Kersting, D; Kreissl, MC; Nagarajah, J; Riemann, B; Rischpler, C; Schmid, KW; Theurer, S; Weber, F; Weber, M | 1 |
Adnan, A; Basu, S; Kumar, R; Raju, S | 1 |
Chan, D; Clifton-Bligh, R; Gild, M; Hoang, J; Maw, AM; Roach, P; Schembri, G; Tacon, L; Wijewardene, A | 1 |
Chamroonrat, W; Charoenphun, P; Sakulpisuti, C | 1 |
Amin, AA; Elahmadawy, MA; Heikal, SY; Shalash, AM; Youssef, AA | 1 |
Dewaraja, YK; Roseland, ME; Wong, KK | 1 |
Keidar, Z; Weiler-Sagie, M; Yechiel, Y | 1 |
Albano, D; Bertagna, F; Bottoni, G; Catrambone, U; Fiz, F; Foppiani, L; Massollo, M; Piccardo, A; Puntoni, M; Trimboli, P | 1 |
Chan, HP; Chen, IF; Kao, CH; Shen, DH; Tsai, FR | 1 |
de Geus-Oei, LF; de Koster, EJ; Oyen, WJG; Vriens, D | 1 |
Basu, S; Sonavane, SN | 1 |
Chen, W; Li, Y; Lin, Z; Zhang, Y | 1 |
Bulzico, DA; Cavalcante, LBCP; Corbo, R; de Andrade, FA; Fernandes, PIW; Garcis Alves-Junior, PA; Gonzalez, F; Treistman, N; Vaisman, F | 1 |
Chae, Y; Kang, BT; Kang, S; Kim, H; Koo, Y; Lee, D; Yang, MP; Yun, T | 1 |
Arıöz Habibi, H; Yılmaz, S | 1 |
De Los Monteros, PE; Familiar, C; Hernández, F; López, C; Merino, S; Pallarés, R; Pascual, AC; Pazos, M; Pérez, X; Valhondo, R | 1 |
Durma, AD; Kamiński, G; Saracyn, M; Zegadło, A | 1 |
Beer, AJ; Eiber, M; Henninger, M; Rischpler, C; Scheidhauer, K; Thaiss, W; Westphal, K | 1 |
Askar, HAA; Bashank, NM; Farghali, RM; Mekkaway, MA | 1 |
Ding, X; Hou, L; Ju, N; Li, C; Luo, Q; Nie, L; Shen, C; Wang, Y | 1 |
Ap Dafydd, D; Fitzhugh, A; Harrington, K; Owens, C; Paleri, V; Sharma, B; Shur, J | 1 |
Chen, Z; Huang, Y; Shi, L; Tang, J; Tang, X; Wang, F; Wang, J; Yang, R; Zhao, Z | 1 |
Cheon, GJ; Cho, SW; Choi, H; Kang, KW; Paeng, JC; Park, YJ; Suh, HY | 1 |
Fei, M; Liu, J; Shi, Y; Tang, L; Wang, Z | 1 |
Lee, H; States, LJ | 1 |
Aghaee, A; Norouzbeigi, N; Roshanravan, V; Sadeghi, R; Zakavi, SR | 1 |
Giovanella, L; Iakovou, I; Luster, M; Mihailovic, J; Treglia, G; Verburg, FA | 1 |
Baltacioglu, F; Dulundu, E; Kesim, S; Ones, T; Ozguven, S | 1 |
Giovanella, L; Treglia, G | 2 |
Cheng, W; Hou, G; Jiang, Y | 1 |
Chen, X; Klubo-Gwiezdzinska, J | 1 |
Hehenwarter, L; Pirich, C; Rendl, G; Rettenbacher, L; Schweighofer-Zwink, G | 1 |
Kim, DH; Kim, SJ | 1 |
Backhaus, P; Riemann, B; Schäfers, M; Schleupner, MC; Vrachimis, A | 1 |
García S, N; Ladrón de Guevara H, D; Letelier B, C; Munizaga M, C; Wash F, A | 1 |
Biermann, M; Brauckhoff, K | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Gao, Q; Guo, X; He, H; Jin, Y | 1 |
Fujita, Y; Maya, Y; Mizukami, T; Shimizu, S; Takei, T | 1 |
Álamo-de-la-Gala, MDC; Calvo-Morón, MC; García-Gómez, FJ; León-Asuero-Moreno, I; Ríos-Martín, JJ | 1 |
Civan, C; Isik, EG; Simsek, DH | 1 |
Danilenko, VV; Kmetyuk, YV; Solodyannikova, OI; Sukach, GG | 1 |
Li, W; Meng, Z; Yin, L | 1 |
Castell-Conesa, J; García-Burillo, A; Iglesias-Felip, C; Monturiol-Duran, JA; Villasboas-Rosciolesi, D | 1 |
Kim, K; Kim, SJ; Lee, SW; Shim, SR | 1 |
Ou, L; Wu, J; Zhang, C | 1 |
Garg, R; Jain, TK; Krishnaraju, VS; Kumar, R; Kumar, S; Mittal, BR; Sood, A | 1 |
Gao, J; Gong, R; Gong, Y; Li, Z; Ma, Y; Yang, J; Zhu, J | 1 |
Boni, G; Elisei, R; Giani, C; Guidoccio, F; Minaldi, E; Puccini, G; Puleo, L; Tardelli, E; Valerio, L; Volterrani, D | 1 |
Beissert, M; Bley, TA; Buck, AK; Lapa, C; Mihatsch, PW | 1 |
Goh, HJ; Leow, MKS; Sun, L; Velan, SS; Verma, SK; Wang, NX | 1 |
Chen, L; Cheng, L; Fu, H; Jin, Y; Liu, M; Qiu, X; Sa, R | 1 |
Chen, H; Fu, H; Fu, J; Huang, J; Pang, Y | 1 |
Ayan, A; Basaran, Y; Cinar, A; Kirnap, NG | 1 |
Baek, JH; Chang, YH; Chen, WC; Chi, SY; Chiang, PL; Chou, CK; Huang, SC; Lin, WC; Luo, SD; Su, YY; Tung, YC | 1 |
Işık, EG; Kuyumcu, S; Sanli, Y | 1 |
Naidoo, K; Shah, K; Sudha Surasi, DS; Yadav, D | 1 |
Bardet, S; Ciappuccini, R; Clarisse, B; Dorbeau, M; Giffard, F; Licaj, I; Poulain, L; Saguet-Rysanek, V | 1 |
Brodowska-Kania, D; Dymus, J; Dziuk, M; Kaminski, G; Kolodziej, M; Lubas, A; Mazurek, A; Saracyn, M | 1 |
Chen, Z; Hou, S; Jiang, N; Lin, C; Lin, Q; Qi, Q; Zhang, L | 1 |
Choi, EK; Chong, A; Ha, JM; Jung, CK; Kim, SH; O, JH | 1 |
Asmar, A; Asmar, M; Bülow, J; Simonsen, L | 1 |
Bertrand, AS; Cailleaux, M; Callonnec, F; Edet-Sanson, A; Le Cloirec, J; Lussey-Lepoutre, C; Menard, JF; Quieffin, F; Vera, P | 1 |
Bible, KC; Jasim, S; Nathan, MA | 1 |
Dettmer, MS; Giger, R; Sachpekidis, C; Wartenberg, J; Weidner, S | 1 |
Giammarile, F; Maffione, AM; Rubello, D | 1 |
Hwang, JP; Kwak, JJ; Lee, SW; Park, JM | 1 |
Antoch, G; Görges, R; Herrmann, K; Keller, HW; Ruhlmann, J; Ruhlmann, M; Ruhlmann, V | 1 |
Castelo, B; Coronado, M; Lecumberri, B; López, E; Rodado, S | 1 |
Cuocolo, A; D'Amico, D; De Matteis, G; Fonti, R; Klain, M; Nicolai, E; Pace, L; Pellegrino, T; Raddi, M; Salvatore, B; Storto, G | 1 |
Davidson, M; Ewton, AA; Olsen, RJ; Robbins, RJ | 1 |
Buchpiguel, CA | 1 |
Abe, T; Fujimoto, K; Kurata, S; Sumi, A; Tani, J; Tsubaki, F | 1 |
Chen, SW; Chen, YK | 1 |
Feely, M; Grajo, JR; Otto, B; Smith, CJ; Wang, MX | 1 |
Ganjoo, KN; Iagaru, A; Yurkiewicz, IR | 1 |
Jayakumar, R; Joy, A; Oommen, KE; Pillai, MRA; Sasikumar, A | 1 |
Rosario, PW | 1 |
Buchpiguel, CA; de Carvalho, JWA; Duarte, PS; Marin, JFG; Sapienza, MT | 1 |
Kim, SJ; Lee, SW; Pak, K; Shim, SR | 1 |
Choi, S; Kim, S; Pahk, K | 1 |
Jebasingh, FK; Naik, D; Prabhu, K; Thomas, N | 1 |
Appetecchia, M; Barnabei, A; Giovanella, L; Lauretta, R; Romanelli, F; Trimboli, P; Valabrega, S | 1 |
Shi, Y; You, J | 1 |
Baek, JH; Choi, YJ; Chung, SR; Kim, HJ; Kim, WG; Lee, JH; Lee, JJ; Lee, YM; Song, DE; Suh, CH; Sung, TY | 1 |
Agrawal, R; Asopa, RV; Malhotra, G; Meshram, V; Sonavane, S; Verma, P | 1 |
Døssing, H; Godballe, C; Lange, NGE; Nguyen, TT; Nielsen, AL; Rohde, M; Thomassen, A | 1 |
Abgral, R; Crouzeix, G; Descourt, R; Salaun, PY; Thuillier, P | 1 |
Ishigame, T; Kofunato, Y; Murakami, Y; Nakano, K; Okada, R; Shimura, T; Suzuki, S; Takenoshita, S; Yashima, R | 1 |
Cha, W; Goh, TS; Han, ME; Jang, JY; Jeong, DC; Kim, IJ; Kim, SJ; Kim, YH; Lee, CS; Pak, K; Suh, S | 1 |
Avram, AM; Beesley, LJ; Bellile, EL; Manohar, PM; Worden, FP | 1 |
Bahl, A; Gulati, A; Kumar, R; Mittal, BR; Parihar, AS; Prakash, G; Singh, S; Singhal, M; Sood, A | 1 |
Hsieh, YJ; Ke, CC; Liang, TJ; Lin, YS; Liu, RS; Liu, SI; Lu, TY; Peng, NJ; Su, HH; Tai, HT | 1 |
Ariga, S; Dosaka-Akita, H; Gouda, T; Hirata, K; Homma, A; Homma, R; Iijima, H; Kinoshita, I; Magota, K; Ohhara, Y; Shiga, T; Shimizu, Y; Taguchi, J; Takeuchi, S; Tamaki, N; Tsuji, Y | 1 |
Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
Hu, Y; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
Choudhury, PS; Gupta, M | 1 |
Bagir, GS; Ertorer, ME; Haydardedeoglu, FE; Kocer, E; Reyhan, M; Torun, N | 1 |
Huss, S; Rahbar, K; Schülke, C; Stegger, L; Wenning, C | 1 |
Moreno, AJ; Wang, B | 1 |
Gao, R; Gao, S; Jia, X; Wang, H; Zhang, G | 1 |
Ding, Y; Ma, C; Wang, H; Wu, S; Xu, J | 1 |
Aporowicz, M; Diakowska, D; Kaliszewski, K; Knychalski, B; Sutkowski, K; Wojtczak, B; Ziętek, M | 1 |
Cortés-Romera, M; Cos-Domingo, M; Gámez Cenzano, C; Moreno-Llorente, P; Pérez-Maraver, M; Reynés-Llompart, G; Rodríguez-Bel, L; Rossi-Seoane, S; Sabaté-Llobera, A; Vercher Conejero, JL | 1 |
Albano, D; Bertagna, F; Giovanella, L; Giubbini, R; Treglia, G | 1 |
Antwi, K; Christ, E; Nicolas, G; Wild, D | 1 |
Borzì, G; Frasca, F; Gullo, D; Ilenia, M; Malandrino, P; Russo, M | 1 |
Albano, D; Durmo, R; Giubbini, R | 1 |
Elshemey, WM; Fathy, M; Khalil, MM; Mohamed, HS | 1 |
Cho, DH; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Na, MH; Song, HC; Yoo, SW | 1 |
Beddell, G; Ivanov, N; Vaiciunaite, D | 1 |
Bin, J; Gege, Z; Lin, B; Qichang, W; Qingjie, M; Renjie, W; Youjia, Z | 1 |
Auerbach, MS; Yu, R | 1 |
Abdel-Halim, CN; Bay, M; Bjørndal, K; Døssing, H; Godballe, C; Jakobsen, J; Madsen, AR; Nielsen, AL; Rosenberg, T; Thomassen, A | 1 |
Abgral, R; Benoudiba, F; de Mones, E; Garcia, G; Garrel, R; Mouawad, F; Pondaven, S; Russ, G; Rysman, B; Tronche, S; Zerdoud, S | 1 |
Bang, JI; Chung, JK; Kang, KW; Kang, SY; Lee, HY | 1 |
Cornic, M; Edet-Sanson, A; Laberge-Le Couteulx, S; Lansoy-Kuhn, C; Mechken, F; Picquenot, JM; Vera, P | 1 |
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
Ceriani, L; Foppiani, L; Giovanella, L; Piccardo, A; Treglia, G; Trimboli, P; Verburg, FA | 1 |
Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakabeppu, Y; Nakajo, M; Tanabe, H; Tani, A | 1 |
Bonnema, SJ; Brix, TH; Hegedüs, L; Soelberg, KK | 3 |
Aras, G; Kucuk, NO; Ozkan, E | 1 |
Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, CH | 1 |
Brouwers, AH; Jansen, L; Links, TP; Muller Kobold, AC; Phan, HT; Plukker, JT; Sluiter, WJ; van der Horst-Schrivers, AN; van Dijk, D | 1 |
Halac, M; Kabasakal, L; Kanmaz, B; Maecke, H; Önsel, Ç; Sager, S; Uslu, L | 1 |
Banzo, I; Carril, JM; Martínez-Rodríguez, I | 1 |
Dunne, RM; McDermott, R; O'Keeffe, SA; O'Mahony, D; Wilson, G | 1 |
Bongiovanni, M; Ceriani, L; Franscella, S; Giovanella, L; Paone, G; Treglia, G | 1 |
Arcelus Martínez, JI; Becerra Massare, P; Bueno Laraño, P; Cañadas Garre, M; Coll Del Rey, E; Esteva Martínez, D; Ferrón Orihuela, JA; López de la Torre, M; Muñoz Pérez, N; Muros Fuentes, MA; Villar del Moral, JM | 1 |
Cho, SB; Chung, CY; Joo, YE; Kim, JS; Lee, WS; Min, JJ; Myung, DS; Park, HC | 1 |
Drescher, R; Freesmeyer, M; Lesser, T; Müller, A | 1 |
Bae, JS; Baek, KH; Cha, BY; Jung, CK; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, SH; Lim, DJ | 1 |
Kim, H; Kim, IJ; Kim, K; Kim, SJ | 1 |
Ito, S; Iwano, S; Kawai, H; Naganawa, S; Ogawa, H; Sakurai, Y | 1 |
Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Pak, K | 1 |
Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M | 1 |
Akkas, BE; Demirel, BB; Vural, GU | 1 |
Bertagna, F; Ceriani, L; Giovanella, L; Sadeghi, R; Treglia, G; Verburg, FA | 1 |
Jeon, YK; Kim, BH; Kim, H; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK | 1 |
Bongaerts, AH; Coppes, MH; Glaudemans, AW; Links, TP; Wolffenbuttel, BH | 1 |
Kim, YJ; Lee, DH; Lee, JW; Lee, SM | 1 |
Ishii, A; Koizumi, M; Nakadate, M; Nakagawa, T; Ryu, Y; Shibuya, H; Suzuki, Y; Tochigi, N; Umehara, I; Yoshida, K | 1 |
Califano, I; Califano, L; Coduti, M; Otero, J; Quildrian, S; Rojas Bilbao, E | 1 |
Bender, LW; Manzil, FF; Scott, JW | 1 |
Ahn, BC; Hong, CM; Jeong, SY; Lee, J; Lee, SW | 1 |
Dai, Q; Jiang, YX; Lai, XJ; Zhang, B; Zhao, RN | 1 |
Abe, K; Akamatsu, G; Baba, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Mizoguchi, N; Sasaki, M | 1 |
Schembri, GP; Sounness, BD | 1 |
Asti, M; Cremonini, N; Erba, PA; Filice, A; Fioroni, F; Frasoldati, A; Fraternali, A; Froio, A; Putzer, D; Sollini, M; Versari, A | 1 |
Asa, S; Halaç, M; Kabasakal, L; Kanmaz, B; Maecke, H; Ocak, M; Önsel, Ç; Sager, G; Sager, S; Uslu, L | 1 |
Giovanella, L; Salvatori, M; Treglia, G | 1 |
Ouvrier, MJ; Thariat, J; Vignot, S | 1 |
Abhyankar, A; Basu, S | 1 |
Azuma, K; Fujimoto, K; Fujita, H; Hattori, S; Hayabuchi, N; Hayakawa, M; Hiromatsu, Y; Hirose, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kurata, S; Nakashima, T; Takamori, S | 1 |
Behrendt, FF; Kelders, A; Kennes, LN; Krohn, T; Mottaghy, FM; Verburg, FA | 1 |
Bongiovanni, M; Ceriani, L; Giovanella, L; Perriard, U; Treglia, G; Weidner, S | 1 |
Al Bunni, F; Cervino, AR; Evangelista, L; Muzzio, PC; Pomerri, F | 1 |
Abe, S; Fujita, N; Ito, S; Iwano, S; Kato, K; Naganawa, S; Ota, N; Yamamoto, S; Yamashiro, K | 1 |
Chatziioannou, SN; Georgakopoulos, AT; Kafiri, GT; Kallergi, M; Pavlou, SN; Pianou, NK | 1 |
Khiewvan, B; Nopmaneejumruslers, C; Pusuwan, P; Tojinda, N; Tuchinda, P; Ubolnuch, K | 1 |
Cakir, B; Ersoy, R; Özdemir, E; Polat, SB; Turkolmez, S; Yildirim Poyraz, N | 1 |
Cheon, GJ; Choi, HS; Chung, JK; Kang, KW; Kim, EE; Lee, DS; Lee, KE; Min, HS; Pak, K; Park, YJ | 1 |
Fujita, S; Imai, Y; Katakami, N; Takeshita, J | 1 |
Choi, JS; Choi, Y; Han, KH; Kang, WJ; Kim, EK; Kwak, JY; Moon, HJ; Yoon, JH; Youk, JH | 1 |
Bal, C; Kundu, P; Lata, S; Malhotra, A; Sharma, P; Singh, H | 1 |
Bal, C; Ballal, S; Jain, TK; Karunanithi, S; Sharma, P; Vijay, MK | 1 |
Ji, QH; Lu, ZW; Qu, N; Wei, WJ; Zhang, L; Zhang, Y | 1 |
Boccaletto, F; Chirillo, F; Olivari, Z; Possamai, M; Scotton, P | 1 |
Berlangieri, S; Eek, R; Murphy, C; Schwalb, H | 1 |
Gupta, MK; Nayan, S; Ramakrishna, J | 1 |
Arecco, F; Bardesono, F; Bertagna, F; Cabria, M; Ceriani, L; Cistaro, A; Foppiani, L; Giovanella, L; Giubbini, R; Naseri, M; Orlandi, F; Piccardo, A; Puntoni, M; Treglia, G | 1 |
Ansquer, C; Barbet, J; Borson-Chazot, F; Bournaud, C; Campion, L; Chatal, JF; Drui, D; Frampas, E; Goldenberg, DM; Kraeber-Bodéré, F; Mathieu, C; Mirallié, E; Robin, P; Rousseau, C; Salaun, PY; Taieb, D; Vuillez, JP | 1 |
Bagnasco, M; Morbelli, S | 1 |
Jiawei, X; Ma, C; Shao, M; Wang, H; Wang, X; Wu, Z; Zhao, L | 1 |
Agrawal, K; Mohan, HK; Weaver, J | 1 |
Adang, EM; de Geus-Oei, LF; de Wilt, JH; Netea-Maier, RT; Oyen, WJ; Smit, JW; Vriens, D | 1 |
Chan, SW; Eviatar, E; Gavriel, H; Tang, A | 1 |
Choi, HH; Hwang, SO; Jung, JH; Kang, JK; Kim, WW; Lee, SW; Park, HY | 1 |
de Keizer, B; Hoekstra, OS; Kist, JW; Stokkel, MP; Vogel, WV | 1 |
Brindle, R; Gandhi, A; Mullan, D; Yap, BK | 1 |
Kang, HC; Kim, HK; Kim, SJ; Kim, SS; Oak, CY; Yoon, JH | 1 |
Knoll, P; Kudlacek, M; Mirzaei, S; Pokieser, W; Sonneck-Koenne, C; Zandieh, S | 1 |
Cheng, W; Fu, H; Liang, S; Tang, Y; Wang, H; Wu, S; Wu, Z; Ye, Z | 1 |
Bueno, F; Cross, G; Pitoia, F | 1 |
Cai, L; Chen, Y; Huang, Z; Wu, J | 1 |
Bomanji, J; Panagiotidis, E | 1 |
Huang, R; Kuang, A | 1 |
Santhanam, P; Taïeb, D | 1 |
Chang, HS; Jeon, TJ; Lee, JH; Lee, YS; Ryu, YH | 1 |
Liang, S; Ma, C; Wang, H; Zhang, L | 1 |
Inoue, T; Jinnouchi, S; Minamimoto, R; Senda, M; Terauchi, T; Yoshida, T | 1 |
Kowalska, A; Lesiak, J; Młynarczyk, J; Trybek, T | 1 |
Bochev, P; Chaushev, B; Dancheva, J; Encheva, E; Hristozov, K; Klisarova, A; Krasnaliev, I; Nenkov, R; Radev, R; Yordanov, K; Yordanova, C | 1 |
Aksoy, SY; Aliyev, A; Asa, S; Halac, M; Ozhan, M; Sager, S; Sonmezoglu, K; Uslu, L; Vatankulu, B | 1 |
Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
Flukes, S; Lenzo, N; Moschilla, G; Sader, C | 1 |
Basu, S | 1 |
Bastos, CR; Braga, JU; Caetano, R; da Silva, RM; de Oliveira, IA; Fortes, CP; Pepe, VL; Reis, LG | 1 |
Bączyk, M; Czarnywojtek, A; Czepczyński, R; Janicka-Jedyńska, M; Lodyga, M; Ruchała, M; Stangierski, A; Woliński, K; Wyszomirska, A | 1 |
Evangelista, L; Farsad, M; Pelizzo, MR; Piotto, A | 1 |
Chung, JK; Kim, MJ; Youn, H | 1 |
Adalet, I; Aral, F; Gecer, MF; Kuyumcu, S; Ozel, S; Ozkan, ZG; Uzum, AK | 1 |
Lauridsen, JK; Rohde, M; Thomassen, A | 1 |
Antonelli, A; Grosso, M; Guidoccio, F | 1 |
Jacques, T; Sharma, SD; Smith, S; Watters, G | 1 |
Assante, R; Fonti, R; Klain, M; Nicolai, E; Pace, L; Pellegrino, T; Salvatore, B; Salvatore, M; Storto, G; Zampella, E | 1 |
Baudin, E; Blanchard, P; Deandreis, D; Deutsch, E; Ghuzlan, AA; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Levy, A; Lumbroso, J; Schlumberger, M; Tao, Y | 1 |
Gaertner, FC; Hattori, N; Ito, YM; Manabe, O; Okamoto, S; Shiga, T; Tamaki, N; Uchiyama, Y | 1 |
Al Ghuzlan, A; Baudin, E; Berdelou, A; Borget, I; Deandreis, D; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Lumbroso, J; Mirghani, H; Nascimento, C; Schlumberger, M | 1 |
Antoniou, A; Ladenson, P; Marcus, C; Rahmim, A; Subramaniam, RM | 1 |
Sarma, M; Sonik, B; Subramanyam, P; Sundaram, PS | 1 |
Basıbuyuk, M; Demir, HD; Elboga, U; Kalender, E; Karaoglan, H; Ozkaya, M; Sahin, E; Yilmaz, M; Zeki Celen, Y | 1 |
Di Traglia, S; Galli, F; Lauri, C; Pizzichini, P; Signore, A | 1 |
Akslen, LA; Biermann, M; Brauckhoff, K; Brauckhoff, M; Haugland, HK; Heinecke, A; Kråkenes, J; Varhaug, JE | 1 |
Cascavilla, A; Legnani, G; Magistrelli, E; Manfredi, R; Sabbatani, S | 1 |
Grewal, RK; Ho, AL; Nagarajah, J; Tuttle, RM; Weber, WA | 1 |
Ciarallo, A; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
Iyamu, I; Mathews, D; Peng, F; Truelson, J; Wachsmann, J | 1 |
Bruna-Muraille, C; Dabakuyo-Yonli, TS; Dalac, A; Dalban, C; Fieffe, S; Guendouzen, S; Masson-Deshayes, S; Papathanassiou, D; Pochart, JM; Schvartz, C | 1 |
Biondi, B; Rufini, V; Salvatori, M | 1 |
Chang, S; Kim, SJ | 1 |
Ahn, BC; Ahn, D; Choi, JH; Kim, H; Na, KJ; Sohn, JH | 1 |
Basu, S; Kand, P; Ranade, R | 1 |
Arlandini, A; Bandelloni, R; Foppiani, L; Massollo, M; Piccardo, A | 1 |
Kroiss, A; Uprimny, C; Virgolini, IJ | 1 |
Kumar, A; Kumar, R; Shamim, SA | 1 |
Jeon, YK; Kim, BH; Kim, H; Kim, IJ; Kim, K; Kim, SJ; Kim, SS; Kim, WJ; Kim, YK | 1 |
Biermann, M; Brauckhoff, K; Haslerud, T; Heinecke, A; Küfner Lein, R; Reisæter, L; Varhaug, JE | 1 |
Bom, HS; Chong, A; Jung, SH; Kim, J; Kwon, SY; Min, JJ; Song, HC | 1 |
Bale, R; Dobrozemsky, G; Kendler, D; Nilica, B; Putzer, D; Traub-Weidinger, T; Virgolini, IJ; von Guggenberg, E | 1 |
Choi, YY; Ji, YB; Kim, JY; Kim, TH; Park, JS; Song, CM; Tae, K | 1 |
Comert, M; Ömür, Ö; Oral, A; Saydam, G; Yazici, B | 1 |
Adas, G; Adas, M; Koc, B; Ozulker, F | 1 |
Llamas Elvira, JM; Muros, MA; Torres Vela, E; Triviño Ibáñez, EM | 1 |
Ichikawa, M; Imagawa, M; Ishizuka, T; Kimura, H; Konoshita, T; Nakaya, T; Okazawa, H; Sakai, A; Wakahara, S; Yamamoto, K | 1 |
Basu, S; Thapa, P | 1 |
Carvalho, DP; Vaisman, F; Vaisman, M | 1 |
Cha, J; Hwang, SH; Jo, K; Kim, D; Lee, N; Yun, M | 1 |
Cestari, DM; Leskov, I; Rasool, N | 1 |
Bach, AM; Fish, SA; Tuttle, RM; Yang, SP | 1 |
Allkemper, T; Burg, MC; Schäfers, M; Stegger, L; Vrachimis, A; Weckesser, M; Wenning, C | 1 |
Jun, S; Kim, H; Nam, HY | 1 |
Arias-Loza, P; Herrmann, K; Higuchi, T; Lapa, C; Maya, Y; Wagner, M; Werner, RA | 1 |
Bae, SK; Ha, TK; Jung, SJ; Kim, TH; Lee, SM; Park, JS; Urm, SH; Yoon, M | 1 |
An, YS; Chung, YS; Kim, JH; Lee, SJ; So, EY; Yoon, JK; Yoon, S | 1 |
Ahn, BC; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
Hsieh, CH; Hsu, HL; Hsueh, C; Huang, SB; Lin, HC; Lin, JD; Tseng, CP; Wang, HM; Wu, MH | 1 |
Camera, L; Ciarmiello, A; Colao, A; De Luca, S; Del Vecchio, S; Faggiano, A; Fonti, R; Salvatore, B; Salvatore, M; Segreto, S | 1 |
Chin, BB; Hoang, JK; Sosa, JA; Yerubandi, V | 1 |
Liu, Y | 2 |
Li, ZG; Lin, ZC; Mu, HY | 1 |
Binse, I; Bockisch, A; Rosenbaum-Krumme, SJ; Ruhlmann, M | 1 |
Binse, I; Bockisch, A; Rosenbaum-Krumme, SJ | 1 |
Bal, C; Damle, NA; Taywade, SK | 1 |
Aras, G; Demir, Ö; Erdoğan, MF; Köse, N; Özkan, E; Ünlütürk, U | 1 |
Allkemper, T; Burg, MC; Heindel, W; Konnert, JR; Noto, B; Riemann, B; Schäfers, M; Stegger, L; Vrachimis, A; Weckesser, M; Wenning, C | 1 |
Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
de Keizer, B; Kist, JW; Vogel, WV | 1 |
Hubbard, J; Mohan, H; Moonim, M; Paschali, A | 1 |
BaBa, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Sasaki, M; Tahara, K | 1 |
Czepczynski, R; Jodlowska, E; Kaznowski, J; Kubiak, K; Michaliszyn, P; Ruchala, M; Stangierski, A; Wolinski, K | 1 |
Al-Thaqfi, S; Hadb, A; Naddaf, SY; Syed, GM | 1 |
Basu, S; Parghane, RV | 1 |
Gubała, E; Jarząb, B; Kalemba, M; Kołosza, Z; Krajewska, J; Król, A; Kropin Ska, A; Kukulska, A; Paliczka-Cies Lik, E; Puch, Z | 1 |
Ceylan, M; Çömlekçi, A; Durak, H; Gedik, A; Güray Durak, M; Koçdor, MA; Özdoğan, Ö; Seçil, M; Şencan Eren, M | 1 |
Chung, HW; Hwang, TS; Kim, B; Kim, SK; Lee, WW; Park, KS; So, Y; Yoo, YB | 1 |
Hassan, A; Riaz, S; Zafar, W | 1 |
Aide, N; Babin, E; Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Michels, JJ; Rame, JP | 1 |
Allen-Auerbach, M; Barrio, M; Czernin, J; Gupta, P; Herrmann, K; Palma Diaz, MF; Schiepers, C; Yeh, MW | 1 |
Chikuta, I; Edo, N; Ishikawa, T; Mashimo, Y; Masugi, H; Morita, K; Ota, S; Sakamoto, T; Seki, N; Tokairin, T | 1 |
Cypess, AM; Doyle, AN; Fox, P; Gautam, S; Gavrila, A; Glasgow, A; Hasselgren, PO; Hennessey, JV; Kolodny, GM; Lee, AJ | 1 |
Choi, EK; Chung, YA; Jeong, HS; Oh, JK; Park, JS; Song, IU | 1 |
Baudin, E; Berdelou, A; Bidault, F; Borget, I; Deandreis, D; Dercle, L; Deschamps, F; Hartl, D; Leboulleux, S; Lumbroso, J; Ricard, M; Schlumberger, M; Terroir, M; Tselikas, L | 1 |
Bisdas, S; Boeßert, P; Fottner, C; Hempel, JM; Kloeckner, R; Krick, S; Miederer, M; Musholt, TJ; Pinto Dos Santos, D; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
Bikas, A; Burman, KD; Desale, S; Garcia, CA; Singh, I; Wartofsky, L | 1 |
Arnous, MM; Lan, X; Sun, X | 1 |
Baroli, A; Bulzonetti, N; Carletti, R; Di Gioia, C; Durante, C; Filetti, S; Gianfrilli, D; Giannetta, E; Graziadio, C; Isidori, AM; Lenzi, A; Longo, F; Pofi, R; Tombolini, V; Verrienti, A | 1 |
Basu, S; Kalshetty, A | 1 |
Bom, HS; Cho, IH; Choi, EK; Chong, A; Chun, KA; Ha, JM; Kim, J; Kim, SH; Kong, EJ; Kwon, SY; Min, JJ; O, JH; Song, HC | 1 |
Corstens, FH; Oyen, WJ; Vogel, WV; Zuijdwijk, MD | 1 |
Allen, TW; Davison, JM; Holley, TS; Jurgens, JS; Montilla-Soler, JL; Stack, AL; Stocker, DJ | 1 |
Conrad, GR; Jackson, RT; Sinha, P | 1 |
Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 1 |
Cho, A; Kim, EK; Kim, MJ; Kwak, JY; Oh, KK; Son, EJ; Yun, M | 1 |
Katz, SC; Shaha, A | 1 |
Hung, GU; Lee, KW; Liao, PY; Yang, KT; Yang, LH | 1 |
Dierckx, RA; Jager, PL; Links, TP; Phan, HT; Plukker, JT; Wolffenbuttel, BH | 2 |
Hsu, CH; Lee, CJ; Lin, SE; Tai, CJ | 1 |
Juweid, M; Milhem, M; O'Dorisio, T | 1 |
Ahuja, AT; Choi, FP; Lee, YY; Wong, KT | 1 |
Geller, MD; Gerard, PS; Mattern, M | 1 |
Chiofalo, MG; Corazzelli, G; De Chiara, A; Franco, R; Pezzullo, L | 1 |
Agrawal, A; Hall, NC; Martin, EW; Povoski, SP; Ringel, MD | 1 |
Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
Cherk, MH; Moore, M; Serpell, J; Swain, S; Topliss, DJ | 1 |
Jain, MK; Spratt, SE; Wong, TZ | 1 |
Giachetti, M; Lupi, A; Malfatti, V; Orsolon, P; Salgarello, M; Zanco, P | 1 |
Jun, JY; Manni, A | 1 |
Larson, SM; Robbins, RJ | 1 |
Camargo, RY; Cerci, JJ; Meneghetti, JC; Pereira, MA; Sebastianes, FM; Soares Júnior, J; Tomimori, EK; Zanoni, PH | 1 |
Bergman, J; Kauhanen, S; Korsoff, P; Minn, H; Nuutila, P; Ovaska, J; Salmela, P; Saltevo, J; Sane, T; Seppänen, M; Välimäki, M | 1 |
Alavi, A; Basu, S; Bural, G; Li, G | 1 |
Mehta, P; Roman, S; Sosa, JA | 1 |
Carty, SE; Stang, MT | 1 |
Balogh, J; Dahele, M; Ehrlich, L; Silverberg, J; Ung, YC; Wong, CS | 1 |
Beheshti, M; Broinger, G; Dralle, H; Kohlfürst, S; Langsteger, W; Nader, M; Pirich, C; Pöcher, S; Vali, R; Waldenberger, P | 1 |
Auperin, A; Bournaud, C; Busaidy, NL; Corone, C; Ewertz, ME; Jacene, HA; Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR; Sherman, SI; Wahl, RL | 1 |
Chung, SK; Chung, YA; Kim, CH; Kim, SH; Park, YH; Sohn, HS; Yoo, IeR | 1 |
Alavi, A; Chen, W; Parsons, M; Torigian, DA; Zhuang, H | 1 |
Baik, SH; Beak, SK; Choi, DS; Kim, NH; Kim, SG | 1 |
Brett, EM; Desai, SC; Eloy, JA; Fatterpekar, GM; Genden, EM; Kostakoglu, L; Som, PM | 1 |
Baek, KH; Kang, MI; Kim, GS; Kim, MK; Kim, SY; Lee, KW; Park, WC; Sohn, HS; Song, KH | 1 |
Esteva, D; Jiménez Alonso, J; Llamas-Elvira, JM; López de la Torre, M; Muros, MA; Muros, T; Villar, JM | 1 |
Clerc, J | 1 |
Avram, AM; Cahill, JM; Frey, KA; Wong, KK; Zarzhevsky, N | 1 |
Lee, SK; Rho, BH | 2 |
Dong, MJ; Liu, ZF; Luo, XG; Ruan, LX; Sun, F; Wang, GL; Yang, SY; Zhao, K | 1 |
Chen, L; Luo, Q; Shen, Y; Wu, X | 1 |
Chisholm, EJ; Tolley, NS | 1 |
Inoue, T; Jinnouchi, S; Kawamoto, M; Minamimoto, R; Nakashima, R; Nishizawa, S; Senda, M; Terauchi, T; Yoshida, T | 1 |
Fremont, V; Hartmann, A; Kuwert, T; Maschauer, S; Prante, O; Reinfelder, J; Stoehr, R; Szkudlinski, M; Weintraub, B | 1 |
Aurengo, A; Leenhardt, L; Lloret Linares, C; Sellier, P; Troisvallets, D | 1 |
Bomanji, JB; Caplin, M; Conry, BG; Kayani, I; Mahmood, S; Papathanasiou, ND; Prakash, V | 1 |
Bae, JS; Chae, BJ; Jung, SS; Kim, JS; Kim, SH; Park, WC; Song, BJ | 1 |
Abe, K; Baba, S; Hatakenaka, M; Honda, H; Kaneko, K; Sasaki, M; Tanabe, Y; Yabuuchi, H | 1 |
Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
Bihan, H; Cohen, R; des Guetz, G; Martin, A; Wind, P | 1 |
Chao, TC; Hsueh, C; Lin, JD | 1 |
Li, B; Xu, H; Zhai, G; Zhang, M; Zhu, C | 1 |
Al-Nahhas, A; El-Refai, S; Hodolic, M; Khan, S; Marzola, MC; Naji, M; Rubello, D | 1 |
Alavi, A; Bertagna, F; Biasiotto, G; Bosio, G; Gabanelli, S; Giubbini, R; Lucchini, S; Merli, G; Puta, E; Rodella, C; Rosenbaum, J; Savelli, G | 1 |
Klain, M; Nicolai, E; Pace, L; Salvatore, M | 1 |
Björo, T; Bogsrud, TV; Hay, ID; Karantanis, D; Kasperbauer, JL; Lowe, VJ; Mullan, BP; Nathan, MA; Reading, CC; Wiseman, GA | 2 |
Basuyau, JP; d'Anjou, J; Edet-Sanson, A; Hapdey, S; Hitzel, A; Kuhn-Lansoy, C; Modzelewski, R; Vera, P | 1 |
Borschitz, T; Eichhorn, W; Fottner, C; Hansen, T; Lang, H; Musholt, TJ; Schad, A; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
Abe, K; Baba, S; Hatakenaka, M; Honda, H; Isoda, T; Kaneko, K; Sasaki, M; Yabuuchi, H | 1 |
Baek, JH; Hong, SJ; Kim, ES; Kim, EY; Kim, TY; Kim, WB; Kim, WG; Lee, JH; Ryu, JS; Shong, YK; Yoon, JH | 1 |
Knuth, A; Samaras, P; Soyka, JD; Stenner-Liewen, F; Weber, A; Zaugg, K; Zweifel, M | 1 |
Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
Bartel, TB; Bodenner, D; Nalley, C; Stack, BC; Wiebeck, K | 1 |
Inubushi, M; Iwaki, H; Matsunaga, H; Matsushita, A; Nagayama, K; Nakamura, H; Nishizawa, S; Ohba, K; Okada, H; Oki, Y; Sasaki, S; Suzuki, S | 1 |
Grünwald, F; Happel, C; Kranert, WT; Middendorp, M; Selkinski, I | 1 |
Basu, S; Menon, S | 1 |
Meyer, P | 1 |
Ahn, EJ; Hwang, I; Lee, SK; Yeo, SH | 1 |
Alevizaki, M; Datseris, IE; Piaditis, G; Rondogianni, P; Skoura, E; Tolis, G; Tsagarakis, S; Tzanela, M | 1 |
Avram, A; Djekidel, M; Gordon, M; Gross, MD; Shah, RB | 1 |
Ben-Levi, E; Naidich, JJ; Nguyen, VT; Palestro, CJ; Rini, JN; Yi Li, J | 1 |
Cho, A; Choi, YJ; Hong, SW; Kim, CK; Lee, JD; Noh, TW; Park, CS; Yun, M | 1 |
Chabrier, G; Detour, J; Goichot, B; Greget, M; Imperiale, A; Keomany, J; Pessaux, P; Rust, E | 1 |
Gao, Y; Lou, Y; Ma, C; Wang, X; Xie, J; Zuo, S | 1 |
Lin, M; London, K | 1 |
Basu, S; Shet, T | 1 |
Hickeson, M; Makis, W; Novales-Diaz, JA | 2 |
Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, CH | 1 |
Agrawal, A; Agrawal, R | 1 |
Cuganesan, R; Lin, M; Lin, P; Shon, IH; Som, S; Wong, C | 1 |
Iizuka, K; Mizoguchi, K; Morita, S; Suzuki, M | 1 |
Barollo, S; Busnardo, B; Girelli, ME; Mantero, F; Merante Boschin, I; Mian, C; Nacamulli, D; Negro, I; Pelizzo, MR; Pennelli, G; Rugge, M; Vianello, F; Watutantrige Fernando, S | 1 |
Al Ghuzlan, A; Aupérin, A; Baillot, S; Baudin, E; Bidault, F; Bonniaud, G; Deandreis, D; Leboulleux, S; Lumbroso, J; Poisson, T; Schlumberger, M; Travagli, JP | 1 |
Asopa, RV; Garde, PS; Gawde, S; Malhotra, G; Rangarajan, V; Sridhar, E; Upadhye, TS | 1 |
Celi, FS; Cochran, CS; Davis, JL; Hughes, M; Merino, MJ; Reynolds, JC; Wolff, EF | 1 |
Lang, BH; Law, TT | 2 |
Kim, BH; Kim, IJ; Kim, SJ; Kim, YK; Na, MA | 1 |
Bommireddipalli, S; DePuey, EG; Gadiraju, R; Goel, S; Paniz-MondolFi, A | 1 |
Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Singh, B | 1 |
Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
Baek, JH; Choi, BS; Choi, JW; Jeong, KS; Kim, TY; Kim, WB; Lee, JH; Ryu, JS; Shong, YK | 1 |
Hyun Yoon, J; Jung Moon, H; Kim, EK; Min Jeon, H; Young Kwak, J | 1 |
Choe, JH; Choi, JH; Choi, JY; Hur, SM; Kim, JH; Kim, JS; Kim, S; Kim, SH; Kim, WW; Lee, JE; Lee, SK; Nam, SJ; Yang, JH | 1 |
Choi, JY; Chung, JH; Jang, HW; Kim, HK; Kim, SW; Lee, JI; Shin, HW; Shin, JH | 1 |
Cheng, SP; Huang, TS; Lee, JJ; Lin, YC | 1 |
Asopa, R; Malhotra, G; Rajan, MG | 1 |
Bertagna, F; Giubbini, R | 3 |
Bertagna, F; Biasiotto, G; Bosio, G; Giubbini, R; Orlando, E | 1 |
Al Ghuzlan, A; Baudin, E; Bidart, JM; Caillou, B; Deandreis, D; Garsi, JP; Lacroix, L; Leboulleux, S; Lumbroso, J; Schlumberger, M; Talbot, M | 1 |
Choi, JW; Kim, SM; Koo, BS; Yoon, YH | 1 |
Bruna-Muraille, C; Cuif-Job, A; Guedec-Ghelfi, R; Liehn, JC; Papathanassiou, D; Pochart, JM | 1 |
Ho, L; Kaushik, A | 1 |
Ahmadzadehfar, H; Biermann, K; Biersack, HJ; Sabet, A | 1 |
Li, HS; Wang, MF; Wang, QS; Wu, HB | 1 |
Kaji, M; Kanazawa, S; Katayama, N; Katsui, K; Okumura, Y; Sato, S; Suzuki, E; Takemoto, M; Yoshio, K | 1 |
Benz, MR; Bockisch, A; Czernin, J; Damoiseaux, RD; Hartung, V; Hildebrandt, IJ; Laing, RE; Phelps, ME; Walter, MA; Weber, WA | 1 |
Hickeson, M; How, J; Nishimori, H; Tabah, R | 1 |
Altrinetti, V; Barbera, F; Bianchi, P; Biscaldi, E; Cabria, M; Foppiani, L; Morbelli, S; Piccardo, A; Villavecchia, G | 1 |
Alavi, A; Basu, S; Rosenbaum, J; Urhan, M | 1 |
Campbell, P; Clark, JR; Depcynzski, B; Ho Shon, I; Lin, M; Lin, P; Wong, V | 1 |
Ahmad, A; Barakat, FH; Chuang, HH; Fowler, NH; Habra, MA; Myers, JN; Shahani, S; Stava, C | 1 |
Ceriani, L; Giovanella, L; Maffioli, M; Suriano, S | 1 |
Alberini, JL; Bellet, D; Champion, L; Edeline, V; Giraudet, AL; Madar, O; Paulmier, B; Pecking, AP; Poinsignon, A | 1 |
Bockisch, A; Freudenberg, LS; Jentzen, W; Rosenbaum-Krumme, SJ; Stahl, A | 1 |
Ho, TY; Lin, KJ; Liou, MJ; Yen, TC | 1 |
Bom, HS; Byun, BH; Chong, A; Hong, SP; Kang, SR; Kim, DY; Kim, J; Min, JJ; Oh, JR; Song, HC; Yoo, SW | 1 |
Aimaretti, G; Appetecchia, M; Baldelli, R; Boldorini, R; Isidoro, C; Marzullo, P; Morani, F; Pagano, L; Prodam, F; Rudoni, M; Samà, MT; Valente, G | 1 |
Hattori, S; Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kage, M; Kaida, H; Kawahara, A; Kobayashi, M; Kurata, S; Mihashi, H; Nakashima, T; Taira, T; Uchida, M; Umeno, H; Yamada, K | 1 |
Gong, G; Hong, SJ; Hwang, DW; Lee, AL; Lee, JH; Lee, SR; Lee, YM; Park, KM; Sung, TY; Yoon, JH | 1 |
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Kuroki, M; Mizutani, Y; Nagamachi, S; Nakada, H; Nishii, R; Tamura, S; Uchino, N; Wakamatsu, H | 1 |
Chong, A; Heo, SH; Jeong, SY; Lim, JH; Min, JJ; Oh, JR | 1 |
Bennedbæk, FN; Nielsen, MH; Nygaard, B; Søndergaard, SB | 1 |
Castellani, M; Ceriani, L; De Palma, D; Giovanella, L; Suriano, S; Verburg, FA | 1 |
Benson, R; Chicco, A; Lin, M; Wong, C | 1 |
Arabi, M; Dvorak, R; Gross, MD; Kujawski, L; Smith, LB | 1 |
Choi, WH; Chung, YA; Han, EJ; Lee, SH; Sohn, HS | 1 |
Chiu, NT; Hsiao, YC; Lee, BF; Peng, SL; Wu, PS; Yao, WJ | 1 |
Han, JM; Jeon, MJ; Kim, TY; Kim, WB; Rhim, SC; Shong, YK; Yim, JH | 1 |
Feng, HJ; Hu, R; Liu, JH; Ouyang, W; Sun, YG | 1 |
Erbay, G; Ibis, E; Kucuk, ON; Ozkan, E; Soydal, C | 1 |
Bodenner, D; Fan, C; Francis, CL; Nalley, C; Stack, BC | 1 |
Chung, SK; Kim, SH; Lin, C; Lin, Q; Na, SJ; O, JH; Yoo, IeR | 1 |
Li, H; Li, Y; Liang, S; Liu, J; Zhang, Y; Zhu, G | 1 |
Hong, HS; Jung, CH; Kang, SK; Kim, BY; Kim, CH; Kim, JW; Kwak, JJ; Lee, SW; Mok, JO; Park, JM | 1 |
Arnberg, F; Nilsson, IL; Sundin, A; Zedenius, J | 1 |
Ahn, BC; Hwang, MH; Jeon, YH; Jeong, SY; Kim, JE; Lee, J; Lee, SW | 1 |
Adam, G; Apostolova, I; Bannas, P; Derlin, T; Groth, M; Klutmann, S; Mester, J | 1 |
Dvorak, RA; Grassetto, G; Gross, MD; Marzola, MC; Rubello, D; Wong, KK | 1 |
Ziessman, HA | 1 |
Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S | 1 |
Iagaru, A; Mosci, C | 1 |
Choong, KW; Eng, JA; Jackson, TA; Knapp, PE; McAneny, D; Subramaniam, RM | 1 |
Collins, C; Cotter, M; Evoy, D; Gibbons, D; McDermott, E; Prichard, RS; Skehan, S | 1 |
Kao, YH; Lim, SS; Ong, SC; Padhy, AK | 1 |
Chaiwatanarat, T; Kingpetch, K; Pipatrattana, R; Sirisalipoch, S; Tepmongkol, S | 1 |
Ito, S; Iwano, S; Kato, K; Naganawa, S; Tsuchiya, K | 1 |
Ambrosini, V; Castaldi, P; Cremonini, N; de Waure, C; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Santimaria, M; Treglia, G; Versari, A; Villani, MF | 1 |
Bae, JS; Baek, KH; Cha, BY; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, KW; Lim, DJ; O, JH | 1 |
Bockisch, A; Grabellus, F; Nagarajah, J; Schmid, KW; Sheu, SY | 1 |
Al Ghuzlan, A; Auperin, A; Baudin, E; Caillou, B; Chami, L; Deandreis, D; Hartl, D; Leboulleux, S; Lumbroso, J; Schlumberger, M; Travagli, JP; Vielh, P | 1 |
Asao, T; Fujii, T; Kuwano, H; Tsutsumi, S; Yajima, R; Yamaguchi, S | 1 |
Bonabi, S; Broglie, MA; Haile, SR; Schmidt, F; Stoeckli, SJ | 1 |
Jin, J; McHenry, CR | 1 |
Cheng, X; Liang, ZY; Lin, YS; Qiu, LH | 1 |
Campbell, DB; Crist, HS; Kaul, S; Manni, A; Tulchinsky, M | 1 |
Chondrogiannis, S; Evangelista, L; Gross, MD; Laird, AM; Marzola, MC; Moubayed, A; Rubello, D; Wong, KK | 1 |
Bom, HS; Byun, BH; Chong, A; Hong, SP; Jeong, UG; Min, JJ; Song, HC | 1 |
Czarnywojtek, A; Czepczyński, R; Janicka-Jedyńska, M; Oleksa, R; Ruchała, M; Sowiński, J; Stangierski, A | 1 |
Marzola, MC; Rubello, D | 1 |
Bao, L; Cheng, X; Li, D; Li, Y; Wang, J; Xu, Z | 1 |
Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
Aimaretti, G; Isidoro, C; Morani, F; Pagano, L; Prodam, F | 1 |
Giordano, A; Rufini, V; Treglia, G; Villani, MF | 1 |
Bal, C; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Sharma, P; Suman Kc, S | 1 |
Bockisch, A; Nagarajah, J; Rosenbaum-Krumme, SJ | 1 |
Baek, S; Chung, EJ; Koh, SH; Ku, YJ; Rho, YS; Seo, YL; Yoon, DY | 1 |
Bale, RJ; Eisterer, W; Gabriel, M; Gastl, G; Kendler, D; Kroiss, A; Madleitner, R; Putzer, D; Uprimny, C; Virgolini, IJ | 1 |
Keelawat, S; Kunawudhi, A; Pak-art, R; Tepmongkol, S | 1 |
Aridome, K; Jinguji, M; Kajiya, Y; Mori, S; Nakajo, M; Suenaga, T; Tanaka, S | 1 |
Araz, M; Ibis, E; Kucuk, NO; Ozkan, E; Soydal, C | 1 |
Binse, I; Bockisch, A; Görges, R; Rosenbaum-Krumme, SJ | 1 |
Aide, N; Bardet, S; Crouzeix, G; Michels, JJ; Sevin, E; Vaur, D | 1 |
Bogsrud, TV; Morsing, A | 1 |
Chopra, A; De Noronha, R; Ford, A; Matthews, S | 1 |
Aras, G; Araz, M; Ibis, E; Ozkan, E; Soydal, C | 1 |
Henne-Bruns, D; Hillenbrand, A; Luster, M; Ohlhauser, D; Reske, SN; Weber, T | 1 |
Kauhanen, S; Schalin-Jäntti, C | 1 |
Kohlfürst, S | 1 |
Al Ghuzlan, A; Baudin, E; Bidault, F; Borget, I; Chougnet, C; Déandreis, D; El Bez, I; Elleuch, M; Hartl, D; Leboulleux, S; Lumbroso, J; Mirghani, H; Schlumberger, M | 1 |
Baek, CH; Choe, YS; Choi, JY; Jeong, HS; Kim, BT; Lee, KH; Moon, SH; Oh, YL; Son, YI | 1 |
Iagaru, A; Jeffrey, RB; McDougall, IR; Mosci, C | 1 |
Akkas, BE; Alavi, A; Basu, S; Ercakmak, N; Vural, GU | 1 |
Bertagna, F; Giubbini, R; Piccardo, A; Treglia, G | 1 |
Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF | 1 |
Dennis, K; Hay, JH; Wilson, DC | 1 |
Del Ciello, A; Di Franco, D; Treglia, G | 1 |
An, GI; An, YS; Cheon, GJ; Choi, TH; Chung, WY; Kim, RM; Lee, J; Nah, KY; Oh, YJ; Soh, EY; Yoon, JK | 1 |
Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
Clark, OH; Duh, QY; Gosnell, J; Guerrero, MA; Munoz-Perez, N; Rinkes, IH; Schreinemakers, JM; Shen, WT; Suh, I; Vriens, MR | 1 |
Aktolun, C; Celen, YZ; Elboga, U; Kalender, E; Yilmaz, M | 1 |
Camera, L; Colao, A; Del Prete, M; Esposito, R; Faggiano, A; Fonti, R; Marotta, V; Palmieri, G; Ramundo, V; Salvatore, M; Vitale, M | 1 |
Giovanella, L; Muoio, B; Salvatori, M; Treglia, G | 1 |
Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH | 1 |
Hu, S; Shi, W; Wang, M; Yang, Z; Yao, Z; Zhang, J; Zhang, Y; Zhu, B | 1 |
Luo, QY; Qiu, ZL; Song, HJ; Xue, YL | 1 |
Bahij, el K; Bertagna, F; Biasiotto, G; Bosio, G; Giovannini, E; Giubbini, R; Maroldi, R; Piccardo, A; Treglia, G | 1 |
Dietlein, M; Dorn, R; Kodalle, T; Kuwert, T; Riemann, B; Schmidt, D; Schober, O; Sciuk, J; Uhrhan, K | 1 |
Bartel, TB; Bodenner, DL; Boeckmann, J; Stack, BC | 1 |
Bertagna, F; Di Franco, D; Giovanella, L; Salvatori, M; Treglia, G | 1 |
Asopa, RV; Malhotra, G; Sridhar, E | 1 |
Essamet, W; Palazzo, FF; Pauleau, G; Sebag, F; Taïeb, D | 1 |
Marcus, CS | 1 |
Caobelli, F; Guerra, UP; Pizzocaro, C | 1 |
Larson, SM; Robbins, R | 1 |
Kumnig, G | 1 |
Kalaigian, H; Kolbert, K; Larson, SM; Robbins, RJ; Sonenberg, M; Tuttle, RM; Wang, W | 1 |
Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
Chen, SM; Hsu, CH; Liu, RS; Shih, LS; Wu, CH | 1 |
Alavi, A; Chacko, TK; Hickeson, M; Zhuang, H | 1 |
Aigner, RM; Humer-Fuchs, U; Krippl, P; Schwarz, T; Wehrschuetz, M; Wolf, G | 1 |
Laking, GR; Price, PM | 1 |
Gallowitsch, HJ; Gomez, I; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Matschnig, S | 1 |
Antoch, G; Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, S; Stattaus, J | 1 |
Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
Bascom, D; Fukui, M; Johnson, JT; McCook, B; Meltzer, C; Snyderman, C; Townsend, DW; Zimmer, LA | 1 |
Bredow, J; Franke, WG; Grüning, T; Kropp, J; Tiepolt, C; Zöphel, K | 1 |
Gallowitsch, HJ; Kresnik, E; Lind, P; Mikosch, P; Würtz, FG | 1 |
Gallowitsch, HJ; Gomez, I; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Stettner, H | 1 |
Bourguet, P | 2 |
Reigman, HI; Smit, JW; Stokkel, MP; Verkooijen, RB | 1 |
Dietlein, M; Dressler, J; Eschner, W; Leisner, B; Reiners, C; Schicha, H | 1 |
Bockisch, A; Frilling, A; Görges, R; Liedke, MO; Schmid, KW; Worm, K | 1 |
Changlai, SP; Chen, WK; Hung, MC; Kao, CH; Wu, HS | 1 |
Goerres, GW; Kneifel, S; Merrill, G; Padberg, BC; Schmid, DT; Stoeckli, SJ | 1 |
Chen, YK; Kao, CH; Liu, FY; Yen, RF | 1 |
Hay, ID; Kasperbauer, JL; Lowe, VJ; McIver, B; Mullan, BP | 1 |
Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
Cohen, O; Goshen, E; Karasik, A; Oksman, Y; Rotenberg, G; Zwas, ST | 1 |
Jeong, SY; Kang, HS; Kang, KW; Kim, SK; Kim, SW; Lee, ES; Lee, IG; Sim, JS | 1 |
Diehl, M; Graichen, S; Grünwald, F; Lindhorst, E; Menzel, C | 1 |
Joyce, JM; Kim, CE; Lichter, J; Patel, N | 1 |
Csornai, M; Esik, O; Lengyel, Z; Lesznyák, J; Majtényi, K; Pisch, J; Rékó, G; Trón, L | 1 |
Endo, K; Higuchi, T; Khan, N; Oriuchi, N; Zhang, H | 1 |
Borson-Chazot, F; Bournaud, C; Desuzinges, C; Giammarile, F; Hafdi, Z; Houzard, C; Itti, R; Janier, M; Sassolas, G | 1 |
Boér, A; Esik, O; Godény, M; Herzog, H; Kásler, M; Klein, I; Péter, I; Szakáll, S; Trón, L; Vincze, B | 1 |
Decristoforo, C; Donnemiller, E; Ensinger, C; Froehlich, F; Gabriel, M; Heute, D; Moncayo, R; von Guggenberg, E | 1 |
Aigner, RM; Krippl, P; Schaffler, G; Schwarz, T; Wolf, G | 1 |
Higashi, T; Iida, Y; Ishimori, T; Iwata, M; Kasagi, K; Konishi, J; Matsumoto, K; Misaki, T; Nakamoto, Y; Saga, T | 1 |
Chin, BB; Cohade, C; Ewertz, M; Ladenson, P; Patel, P; Wahl, R | 1 |
Delbeke, D; Martin, WH; Scanga, DR | 1 |
Al-Nahhas, AM | 1 |
Chin, BB; Hammoud, D; Patel, P | 1 |
Borson-Chazot, F; Bournaud, C; Giammarile, F; Hafdi, Z; Houzard, C; Sassolas, G | 1 |
Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
Battmann, A; Bauhofer, A; Béhé, M; Behr, TM; Beuter, D; Gotthardt, M; Gratz, S; Höffken, H; Klose, KJ; Pollum, H; Schurrat, T | 1 |
Schöder, H; Yeung, HW | 1 |
Biancari, F; Biffoni, M; Marchesi, M | 1 |
de Groot, JW; Jager, PL; Kahraman, T; Links, TP; Plukker, JT | 1 |
Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Zak, IT; Zingas, AP | 1 |
AL-Nahhas, A | 1 |
Rohren, EM | 1 |
Alavi, A; Kumar, R; Mandel, S; Zhuang, H | 1 |
Berkhof, J; Hoekstra, OS; Hooft, L; Molthoff, CF; Teule, GJ; van der Veldt, AA; van Diest, PJ | 1 |
Berchem, G; Decker, G; Lasar, Y; Pilloy, W; Snen, M | 1 |
Berkhof, J; Franssen, EJ; Hoekstra, OS; Sturkenboom, MG | 1 |
Agarwala, SS; Andrade, RS; Avril, N; Flickinger, J; Heron, DE; Johnson, J; Kalnicki, S; Wu, A | 1 |
Bossuyt, A; Everaert, H; Lahoutte, T; Poppe, K; Velkeniers, B | 1 |
Ng, DC; Ong, SC; Sundram, FX | 1 |
Low, SC; Sinha, AK; Sundram, FX | 1 |
Andreae, F; Angelberger, P; Dudczak, R; Leimer, M; Li, S; Rodrigues, M; Traub-Weidinger, T; Virgolini, I | 1 |
Gong, G; Hong, SJ; Kim, TY; Kim, WB; Ryu, JS; Shong, YK | 1 |
Füzesi, L; Hamann, A; Hüfner, M; Meller, J; Sahlmann, CO; Schmitz, G; Siefker, U; Struck, J | 1 |
Gladish, GW; Macapinlac, HA; Marom, EM; Munden, RF; Podoloff, DA; Sabloff, BS; Truong, MT; Yi, JG | 1 |
Baehre, M; Gerl, J; Horstmann, O; Meller, B; Meller, J; Sahlmann, C | 1 |
Ell, PJ | 1 |
Macapinlac, HA | 2 |
Endo, K; Higuchi, T; Khan, N; Oriuchi, N | 1 |
Drucker, W; Gonen, M; Grewal, RK; Larson, SM; Reibke, R; Robbins, RJ; Strauss, HW; Tuttle, RM; Wan, Q | 1 |
Bibb, J; Hromas, R; Rabinowitz, I | 1 |
Choi, AY; Wax, BN; Yung, E | 1 |
Gupta, C; Gupta, V; Malani, AK; Rangineni, S | 1 |
Bridji, B; Cariou, B; Carnaille, B; Charbonnel, B; Curtet, C; Dravet, F; Kraeber-Bodéré, F; Le Néel, JC; Mirallié, E; Rousseau, C | 1 |
Bogsrud, TV; Karantanis, D; Lowe, VJ | 1 |
Chu, JS; Hsu, CH; Wu, CH | 1 |
Coche, E; Daumerie, C; De Nayer, P; Godart, V; Weynand, B | 1 |
Dragoiescu, C; Duchateau, CS; Stokkel, MP | 1 |
Driedger, AA; McDonald, T; Pavlosky, W; Saab, G; Urbain, JL; Wong, CY; Yoo, J | 1 |
Biersack, HJ; Bucerius, J; Hortling, N; Jaeger, U; Joe, A; Meyka, S; Palmedo, H; Roedel, R; Strunk, H; Wardelmann, E; Wolff, M | 1 |
Baek, CH; Choi, JY; Chung, JH; Kim, BT; Kim, HJ; Kwon, OJ; Lee, KH; Lee, KS; Park, K; Shim, YM | 1 |
Bleeker-Rovers, CP; Bonenkamp, JJ; Corstens, FH; de Geus-Oei, LF; Mudde, AH; Oyen, WJ; Pieters, GF | 1 |
Dou, Y; Raja, S; Roscoe, KJ; Tronic, B | 1 |
Randolph, GW; Slough, CM | 1 |
Kohlfürst, S; Lind, P | 1 |
Doki, Y; Ichiki, K; Misaki, T; Oya, T; Shimizu, M; Tsuda, M; Usuda, K | 1 |
Bénard, F; Langlois, MF; Leboeuf, R | 1 |
Battmann, A; Bauhofer, A; Béhé, MP; Behr, TM; Beuter, D; Gotthardt, M; Oyen, WJ; Pollum, H; Schipper, M; Schurrat, T | 1 |
Gönen, M; Larson, SM; Pryma, DA; Robbins, RJ; Schöder, H; Yeung, HW | 1 |
Bläser, D; Kuwert, T; Maschauer, S; Prante, O | 1 |
Ambrosini, V; Banti, E; Carpi, A; Fanti, S; Farsad, M; Franchi, R; Muzzio, P; Nanni, C; Rampin, L; Rubello, D | 1 |
Gabriel, M; Greifeneder, M; Heute, D; Li, S; Rodrigues, M; Virgolini, I | 1 |
Gong, G; Hong, SJ; Kim, JM; Kim, SC; Kim, SY; Kim, TY; Kim, WB; Lee, S; Rhee, YS; Shong, YK; Song, JY | 1 |
Baek, CH; Baek, HJ; Choi, JY; Chung, JH; Jeong, HS; Kim, HJ; Ko, YH; Son, YI | 1 |
Hurtado-López, LM; Martínez-Duncker, C | 2 |
Devaux, JY; Duron, F; Grahek, D; Gutman, F; Kerrou, K; Maurel, G; Montravers, F; Périé, S; Saint Guily, JL; Talbot, JN; Younsi, N; Zanotti, P; Zanotti-Fregonara, P | 1 |
Fuechsel, FG; Krause, T; Weidner, S | 1 |
Are, C; Hsu, JF; Larson, SM; Schoder, H; Shah, JP; Shaha, AR | 1 |
Gallowitsch, HJ; Gomez, I; Igerc, I; Kohlfuerst, S; Kresnik, E; Lind, P; Zoller, M | 1 |
Gallowitsch, HJ; Gomez, I; Igerc, I; Kohlfuerst, S; Kresnik, E; Lind, P; Matschnig, S | 1 |
Ben-Yehuda, D; Cohen, T; Freund, HR; Klein, M; Krausz, Y; Nissan, A | 1 |
Holt, E | 1 |
Cho, BY; Choi, MY; Chung, JK; Jeong, JM; Lee, DS; Lee, HY; Lee, MC; Park, DJ; So, Y | 1 |
Baek, CH; Choi, JY; Chung, M; Jeong, HS; Ko, YH; Son, YI | 1 |
Iagaru, A; McDougall, IR | 1 |
Chen, YK; Chen, YL; Cheng, RH; Hsu, CH; Lee, CC; Yeh, CL | 1 |
Fischbein, NJ; Kaplan, MJ; Le, QT; Loo, BW; McDougall, IR; Pinto, H; Quon, A | 1 |
Gulec, SA | 1 |
Bhure, U; Gassmann, N; Koma, AY; Steinert, HC; Stöckli, SJ; Strobel, K | 1 |
Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR | 1 |
Lin, EC | 1 |
Dadras, SS; Leavitt, M; McDougall, IR; Niederkohr, RD | 1 |
Avril, N; Bencherif, B; Bencherif, BB; Branstetter, B; Carty, SE; Degirmenci, B; Joyce, JM; Kuffner, HA; McCook, BM; Mountz, JM; Shammas, A | 1 |
Basu, S; Nair, N; Shet, T; Thorat, M | 1 |
Arnous, W; Beltran, S; Berger, N; Borson-Chazot, F; Bournaud, C; Giammarile, F; Lifante, JC; Peix, JL; Sassolas, G | 1 |
Kato, M; Maeda, M; Morooka, Y; Nakagawa, T; Nakano, H; Shimizu, S; Takeda, K; Terada, N | 1 |
Doddamane, I; Gönen, M; Larson, SM; Ong, SC; Patel, SG; Schöder, H; Shah, JP; Shaha, AR; Tabangay-Lim, IM; Tuttle, RM | 1 |
Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
Akaki, S; Iguchi, T; Kanazawa, S; Matsuoka, J; Mifune, H; Okumura, Y; Omori, M; Sato, S | 1 |
Juengling, FD; Krause, T; Muggli, B; Weidner, S; Weimann, R; Wissmeyer, M | 1 |
Alavi, A; Basu, S | 1 |
Chang, CY; Cherng, SC; Huang, WS; Lin, LF; Lin, YS; Peng, YJ | 1 |
Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
Abe, S; Ikeda, M; Ishigaki, T; Ito, S; Iwano, S; Kato, K; Makino, N; Naganawa, S; Nakano, S; Nishino, M; Tadokoro, M | 1 |
Awasare, S; Baghel, NS; Malhotra, G; Nair, N | 1 |
Barbet, J; Bodet-Milin, C; Carlier, T; Curtet, C; Kraeber-Bodéré, F; Mirallié, E; Rousseau, C | 1 |
D'Amico, D; Della Morte, AM; Klain, M; Nicolai, E; Pace, L; Paone, G; Salvatore, B; Salvatore, M; Storto, G | 1 |
Binns, DS; Drummond, E; Hicks, RJ; Hogg, A; Lau, EW; Shakher, R; Wang, GH | 1 |
Castaldi, P; Maussier, ML; Melis, L; Perotti, G; Rubello, D; Rufini, V; Salvatori, M | 1 |
Chen, FJ; Chen, WK; Fan, W; Song, M; Wei, MW | 1 |
Delorme, S; Fabel, M; Frank-Raue, K; Haberkorn, U; Raue, F | 1 |
Basu, S; Nair, N; Shet, T | 1 |
Ceriani, L; Crippa, S; Giovanella, L; Mazzucchelli, L | 1 |
Cerci, JJ; Chibana, LK; de Camargo, RY; Eluf-Neto, J; Giorgi, MC; Izaki, M; Meneghetti, JC; Pereira, MA; Sebastianes, FM; Soares, J; Tomimori, EK; Zanoni, PH | 1 |
Cunha, ML; Daniel, MM; Funari, MB; Thom, AF; Wagner, J; Yamaga, LY | 1 |
Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kaida, H; Kurata, S; Miyake, I; Uchida, M | 1 |
Iagaru, A; Kalinyak, JE; McDougall, IR | 1 |
Are, C; Ghossein, RA; Hsu, JF; Schoder, H; Shah, JP; Shaha, AR | 1 |
Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
Bodenner, DL; King, DL; Spring, PM; Stack, BC; Walker, R | 1 |
Aide, N; Bardet, S | 1 |
Ansquer, C; Barbet, J; Bardet, S; Borson-Chazot, F; Bournaud, C; Campion, L; Chatal, JF; Goldenberg, DM; Kraeber-Bodéré, F; Mirallié, E; Murat, A; Oudoux, A; Rousseau, C; Salaun, PY; Vuillez, JP | 1 |
Dehdashti, F; Finkelstein, SE; Grigsby, PW; Hall, BL; Moley, JF; Siegel, BA | 1 |
Hall, NC; Kloos, RT | 1 |
Al-Nahhas, A; Banti, E; Fanti, S; Ferdeghini, M; Gross, MD; Nanni, C; Rampin, L; Rubello, D | 1 |
Caetano, R; Coeli, CM; Kuba, VM; Vaisman, M | 1 |
Antoch, G; Bockisch, A; Freudenberg, LS; Frilling, A; Jentzen, W; Kühl, H; Müller, SP | 1 |
Jeon, DG; Kim, MS; Lee, SY; Sim, YS | 1 |
Ansquer, C; Bodet-Milin, C; Bridji, B; Carnaille, B; Charbonnel, B; Curtet, C; Guillan, T; Kraeber-Bodéré, F; Mirallié, E; Murat, A; Resche, I; Rousseau, C | 1 |
de Heide, LJ; Jager, PL; Links, TP; Noordzij, MJ; Wolfenbuttel, BH | 1 |
Mendoza, PL; Ongkeko, EE; Santiago, JF | 1 |
Ehrlich, L; Kahn, HJ; Mackenzie, R; Nofech-Mozes, S; Raphael, SJ | 1 |
Graham, MM; Hoffman, HT; Robinson, RA; Smith, RB | 1 |
Antoch, G; Bockisch, A; Freudenberg, LS; Frilling, A; Görges, R; Jentzen, W; Kühl, H; Rosenbaum, SJ | 1 |
Kim, IJ; Kim, SJ; Kim, YK; Lee, TH | 1 |
Al-Nahhas, A; Hindie, E; Rampin, L; Rubello, D; Toubert, ME | 1 |
Atkins, F; Burman, K; Butler, C; Jonklaas, J; Ousman, Y; Seiboth, L; Van Nostrand, D; Wartofsky, L | 1 |
Cook, G; Harrington, K; John, L; Lee, B; Nutting, C | 1 |
Ng, DC; Osmany, S; Padhy, AK | 1 |
Franc, B; O'Connor, A; Rutherford, GC | 1 |
Kir, KM; Ozkan, E; Tokmak, E | 1 |
Caleo, O; Klain, M; Mancini, M; Maurea, S; Pace, L; Salvatore, B; Salvatore, M; Storto, G | 1 |
Calcagni, ML; Leccisotti, L; Perotti, G; Rubello, D; Rufini, V; Treglia, G | 1 |
Isozaki, O; Kusakabe, K; Maki, M; Okubo, Y; Takano, K; Yoshihara, A | 1 |
Al-Nahhas, A; Khan, S; Lloyd, C; Rubello, D; Szyszko, T; Win, Z | 1 |
Abouzied, ME; Al Sugair, A; Al-Zahrani, AS; Alzahrani, AS; Amin, T; Mohamed, G; Rifai, A; Salam, SA | 1 |
Halac, M; Karyagar, S; Karyagar, SS; Mulazimoglu, M; Ozpacaci, T | 1 |
Kloos, RT | 1 |
Ghossein, RA; Gomez, D; Larson, SM; Rivera, M; Schoder, H; Tuttle, RM | 1 |
Jaimini, A; Mishra, AK; Mondal, A; Saw, SK; Sharma, R; Singh, N; Tripathi, M | 1 |
Dickinson, CZ; Meier, DA; Scott, GC | 1 |
Feine, U; Hanke, JP; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
Adler, LP; Bloom, AD; Shuck, JM | 1 |
Adler, LP; Bloom, AD | 1 |
Ackermann, RJ; Meyer, MA; Sisson, JC; Wahl, RL | 1 |
Bender, H; Biersack, HJ; Bultmann, T; Grünwald, F; Klemm, E; Kozak, B; Menzel, C; Palmedo, H; Ruhlmann, J; Schomburg, A | 1 |
Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
Feine, U; Hanke, JP; Held, J; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
Blount, CL; Dworkin, HJ | 1 |
Fazio, F; Fridrich, L; Kendler, D; Landoni, C; Lucignani, G; Messa, C; Moncayo, R; Riccabona, G | 1 |
Ahmed, M; Bakheet, SM; Hammami, MM; Powe, JE | 1 |
Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C | 1 |
Hautzel, H; Müller-Gärtner, HW | 1 |
Dietlein, M; Scheidhauer, K; Schicha, H; Theissen, P; Voth, E | 2 |
Akashi, Y; Fukumura, T; Ichiya, Y; Kuwabara, Y; Masuda, K; Sasaki, M; Yoshida, T | 1 |
Adams, S; Baum, R; Hör, G; Rink, T; Schumm-Dräger, PM; Usadel, KH | 1 |
Ferlin, G; Gasparoni, P; Rubello, D | 1 |
Dehdashti, F; Moley, JF; Musholt, PB; Musholt, TJ | 1 |
Bakheet, SM; Powe, J | 1 |
Hayashi, N; Ishii, Y; Nakamura, S; Ohtsubo, T; Sadato, N; Saito, H; Sugimoto, K; Takahashi, N; Tsuchida, T; Tsuda, G; Uematsu, H; Waki, A; Yamamoto, K; Yonekura, Y | 1 |
Feine, U | 1 |
Altenvoerde, G; Kuwert, T; Lerch, H; Matheja, P; Schäfers, M; Schober, O | 1 |
Beyer, W; Clausen, M; Grimm-Riepe, C; Lübeck, M; Schirren-Bumann, K; Schlüter, B | 1 |
Chang, CC; Chieng, PU; Huang, TS; Yen, RF | 1 |
Bockisch, A; Brandt-Mainz, K; Müller, SP; Sonnenschein, W | 1 |
James, C; MacGillivray, DC; Starks, M; White, J | 1 |
Bender, H; Biersack, HJ; Fimmers, R; Grünwald, F; Menzel, C; Otte, R; Palmedo, H; Risse, J | 1 |
Börner, AR; Schicha, H; Voth, E; Wagner, R; Wienhard, K | 1 |
Csornai, M; Emri, M; Esik, O; Gödény, M; Kásler, M; Trón, L | 1 |
Jadvar, H; McDougall, IR; Segall, GM | 1 |
Maxon, HR | 1 |
Bicik, I; Engel, H; Krestin, GP; von Schulthess, GK; Wiesner, W | 1 |
Akhurst, T; Finn, RD; Larson, SM; Macapinlac, H; Robbins, RJ; Rosai, J; Wang, W; Yeh, SD | 1 |
Fujii, H; Ide, M; Shohtsu, A; Takagi, S; Takahashi, W; Yasuda, S | 1 |
Ali, A; Alibazoglu, B; Alibazoglu, H; Hollinger, EF; Ingram, SA; LaMonica, G; Willoughby, WA | 1 |
Dworkin, HJ; Wong, CO | 1 |
Cho, BY; Choi, CW; Chung, JK; Hong, SW; Lee, DS; Lee, JS; Lee, MC; Lim, SM; So, Y; Youn, YK | 1 |
Endo, K | 1 |
Bacqai, F; Conti, PS; Durski, JM; Grafton, ST; Singer, PA | 1 |
Bohuslavizki, KH; Clausen, M; Geiss-Tönshoff, M; Klutmann, S; Kröger, S | 1 |
Dinges, HP; Gallowitsch, HJ; Gomez, I; Kresnik, E; Kumnig, G; Lind, P; Matschnig, S; Mikosch, P; Starlinger, M; Unterweger, O | 1 |
Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
Biersack, HJ; Briele, B; Grünwald, F | 1 |
Hoekstra, A; Stokkel, MP; van Rijk, PP | 1 |
Biersack, HJ; Brandt-Mainz, K; Burchert, W; Cremerius, U; Dietlein, M; Feine, U; Grünwald, F; Hiltermann, G; Kälicke, T; Lerch, H; Lietzenmayer, R; Scheidhauer, K; Schober, O | 1 |
de Klerk, JH; Koppeschaar, HP; Stokkel, MP; van Rijk, PP; Zelissen, PM | 1 |
Hill, RH; Larson, SM; Macapinlac, HH; Robbins, RJ; Wang, W | 1 |
Fazzari, M; Kolbert, K; Larson, SM; Macapinlac, H; Robbins, RJ; Rosai, J; Sgouros, G; Tickoo, SK; Wang, W; Yeung, H | 1 |
Gallowitsch, HJ; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Matschnig, S; Mikosch, P; Unterweger, O | 1 |
Dullaart, RP; Jager, PL; Links, TP; van Tol, KM | 1 |
Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, SP; Saller, B | 1 |
Alnafisi, NS; Coates, G; Driedger, AA; Moote, DJ; Raphael, SJ | 1 |
Boerner, AR; Schicha, H; Theissen, P; Voth, E; Wagner, R; Wienhard, K | 1 |
Carpi, A; Casara, D; Rubello, D; Saladini, G | 1 |
Becerra, A; Carreras, JL; Gómez, MJ; Llamas-Elvira, JM; López de la Torre, M; Muros, MA; Muros, T; Ramírez-Navarro, A; Rodríguez-Fernández, A | 1 |
Comans, EF; Hoekstra, OS; Lips, P; Teule, GJ; van der Poest Clement, E; van Mourik, JC | 1 |
Chisin, R; Macapinlac, HA | 1 |
Beuthien-Baumann, B; Bredow, J; Burchert, W; Franke, WG; Hliscs, R; Kropp, J; Kühne, A; Tiepolt, C | 1 |
Bockhorn, M; Broelsch, CE; Clausen, M; Frilling, A; Gassmann, P; Görges, R; Tecklenborg, K | 1 |
Hahn, K; Knesewitsch, P; Linke, R; Manthey, N; Moog, F; Tatsch, K; Tiling, R | 1 |
Biersack, HJ; Grünwald, F | 1 |
Drucker, WD; Ghossein, RA; Larson, SM; Robbins, HK; Robbins, RJ; Sharaf, RN; Smith, A; Tuttle, RM | 1 |
de Klerk, JM; Hordijk, GJ; Stokkel, MP | 1 |
Beyer, W; Bohuslavizki, KH; Buchert, R; Clausen, M; Plotkin, M; Schlüter, B | 1 |
Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Nitzsche, E | 1 |
Chisin, R; Larson, SM; Macapinlac, HA; Ramos, CD; Yeung, HW | 1 |
Ahn, IM; Cho, BY; Chung, JK; Hong, SJ; Kim, S; Lee, DS; Lee, E; Lee, MC; So, Y; Yeo, JS; Youn, YK | 1 |
Abdel-Dayem, HM; Ajoedi, ND; Ansari, SM; Dede, F; Heiba, SI; Jana, S | 1 |
Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
Börner, AR; Hofmann, M; Knapp, WH; Kreipe, HH; Otto, D; Petrich, T; Soudah, B; Weckesser, E; Widjaja, A | 1 |
Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
Davidson, J; McDougall, IR; Segall, GM | 1 |
Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
Becherer, A; Dudczak, R; Kaserer, K; Kletter, K; Leitha, T; Niederle, B; Zettinig, G | 1 |
Chou, C; Cui, R; Yen, TC; Zhu, Z | 1 |
Biersack, HJ; Grünwald, F; Menzel, C; Risse, JH | 1 |
Boers, M; Devillé, W; Hoekstra, OS; Hooft, L; Lips, P; Teule, GJ; van Tulder, MW | 1 |
Bol, A; Constant, EL; Cosnard, G; Daumerie, C; de Volder, AG; Ivanoiu, A; Labar, D; Melin, J; Seghers, A | 1 |
Franc, B; Gauthier-Koelesnikov, H; Helal, BO; Merlet, P; Prigent, A; Schvartz, C; Syrota, A; Toubert, ME | 1 |
Haberkorn, U | 1 |
Bohuslavizki, KH; Brandt-Mainz, K; Bredow, J; Diehl, M; Dietlein, M; Grünwald, F; Körber, C; Lange, H; Matheja, P; Risse, JH | 1 |
Broelsch, EC; Clausen, M; Frilling, A; Görges, R; Tecklenborg, K; Weber, F | 1 |
Arslan, N; Brunt, LM; Cohen, MS; Dehdashti, F; Doherty, GM; Lairmore, TC; Moley, JF | 1 |
Jang, JS; Joo, HJ; Kim, JK; Lee, EJ; Park, CH | 1 |
Agoston, P; Bajzik, G; Dabasi, G; Esik, O; Repa, I; Sinkovics, I; Szakáll, S; Trón, L | 1 |
Gallowitsch, HJ; Gasser, J; Haselbach, H; Heinisch, M; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
Boemer, AR; Hautzel, H; Herzog, H; Krause, BJ; Larisch, R; Mottaghy, FM; Müller-Gärtner, HW; Plotkin, M; Schmidt, D; Vosberg, H | 1 |
Boerner, AR; Fricke, H; Hofmann, M; Knapp, WH; Langen, KJ; Otto, D; Petrich, T; Weckesser, E; Weckesser, M | 1 |
Bouillon, R; De Potter, T; Delaere, P; Drijkoningen, M; Maes, A; Mortelmans, L; Van Damme, B; Van den Bruel, A | 1 |
Börner, AR; Hofmann, M; Knapp, WH; Otto, D; Petrich, T | 1 |
Donnemiller, E; Erler, H; Gabriel, M; Riccabona, G | 1 |
Aigner, RM; Nicoletti, R; Schwarz, T; Wolf, G | 1 |
Ali, A; Dave, N; Reddy, M; Shor, M | 1 |
Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
de Vries, EG; Dullaart, RP; Jager, PL; Links, TP; Piers, DA; Pruim, J; van Tol, KM | 1 |
Taher, MA | 1 |
Fukumura, T; Ichiya, Y; Jingu, K; Kuwabara, Y; Masuda, K; Otsuka, M; Tahara, T; Yoshikai, T | 1 |
Ahonen, A; Joensuu, H; Klemi, PJ | 1 |
Ahonen, A; Joensuu, H | 1 |
115 review(s) available for fluorodeoxyglucose f18 and Thyroid Neoplasms
Article | Year |
---|---|
Effect of metformin on
Topics: Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Mellitus, Type 2; Energy Intake; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney; Liver Neoplasms; Metformin; Mice; Myocardium; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Thyroid Neoplasms; White Matter | 2022 |
Focal Thyroid Incidentalomas on
Topics: Adenocarcinoma; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prevalence; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2021 |
Positron Emission Tomography/Computed Tomography in Thyroid Cancer.
Topics: Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2022 |
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2022 |
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2022 |
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2022 |
Advanced imaging and theranostics in thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Precision Medicine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2022 |
Role of PET/Computed Tomography in Elderly Thyroid Cancer: Tumor Biology and Clinical Management.
Topics: Adenocarcinoma; Aged; Biology; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms | 2020 |
Multimodal imaging of thyroid cancer.
Topics: Adult; Biopsy, Fine-Needle; Carcinoma, Neuroendocrine; Diagnostic Techniques, Endocrine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Diagnostic values of F-18 FDG PET or PET/CT, CT, and US for Preoperative Lymph Node Staging in Thyroid Cancer: A Network Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Neoplasm Staging; Network Meta-Analysis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Preoperative Care; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2021 |
Updated Review of Nuclear Molecular Imaging of Thyroid Cancers.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Molecular Imaging; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2021 |
PET/Computed Tomography in Thyroid Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2021 |
PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2017 |
Clinical significance of patterns of increased [
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2018 |
Diagnostic performance of PET in thyroid cancer with elevated anti-Tg Ab.
Topics: Antibodies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2018 |
[Expression of Galectin-3 in Differentiated Thyroid Carcinoma and Human Bone Marrow Endothelial Cell Marker and Study and Application of the 18F-Fluordeoxyglucose Imaging].
Topics: Biomarkers, Tumor; Blood Proteins; Bone Marrow; Endothelial Cells; Fluorodeoxyglucose F18; Galectin 3; Galectins; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2016 |
Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
Topics: Aged, 80 and over; Carcinoma, Papillary; Chemotherapy, Adjuvant; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Differentiated thyroid cancer theranostics: radioiodine and beyond.
Topics: Ablation Techniques; Biomarkers; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Peptide; Recombinant Proteins; Risk Assessment; Symporters; Theranostic Nanomedicine; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2018 |
F18-choline/C11-choline PET/CT thyroid incidentalomas.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Thyroid Gland; Thyroid Neoplasms | 2019 |
Molecular imaging for neuroendocrine tumours.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Molecular Imaging; Neoplasm Staging; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2019 |
Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Thyroglobulin; Thyroid Neoplasms | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2013 |
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Focal thyroid incidental uptake detected by ¹⁸F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Sex Distribution; Thyroid Neoplasms | 2013 |
[State of the art in nuclear imaging for the diagnosis of bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Thyroid Neoplasms | 2013 |
Risk of malignancy in focal thyroid lesions identified by (18)F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Risk; ROC Curve; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2014 |
Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Enterochromaffin Cells; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
[Application progress of 18F-FDG positron emission tomograph in differentiated thyroid cancer].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed | 2014 |
¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2015 |
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2016 |
A new appraisal of iodine refractory thyroid cancer.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Biological Transport, Active; Carcinoma; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Forecasting; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins B-raf; Signal Transduction; Survival Rate; Symporters; Thyroid Neoplasms; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases | 2015 |
The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
Topics: Autoantibodies; Biomarkers, Tumor; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2016 |
Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.
Topics: Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Heterotaxy Syndrome; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Splenic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2016 |
PET-associated incidental neoplasms of the thyroid.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Medical management of persistent or recurrent differentiated thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Management; Thyroid Neoplasms; Thyroidectomy | 2008 |
The value of positron emission tomography (PET) in the management of patients with thyroid cancer.
Topics: Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
[Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Topics: Adenoma; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2008 |
Medullary thyroid cancer: early detection and novel treatments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Recent developments in predicting thyroid malignancy.
Topics: Biomarkers, Tumor; Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Thyroid Neoplasms; Thyroid Nodule | 2009 |
[Quantitated thyroid scan (123I) of the thyroid nodule: a new molecular imaging].
Topics: Adult; Autoradiography; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Goiter, Nodular; Humans; Hyperthyroidism; Iodine Radioisotopes; Practice Guidelines as Topic; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Time Factors; Ultrasonography, Doppler | 2009 |
Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Young Adult | 2009 |
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Topics: Aged; Biopsy, Fine-Needle; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2009 |
Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Carcinoma, Neuroendocrine; Catecholamines; Cushing Syndrome; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Diagnostic value of FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed | 2009 |
The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Odds Ratio; Radionuclide Imaging; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2010 |
Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Topics: Abdominal Pain; Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Iodine Isotopes; Lithium; Mutation; Ovarian Cysts; Ovarian Neoplasms; Proto-Oncogene Proteins B-raf; Teratoma; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Treatment Outcome | 2010 |
Role of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients affected by differentiated thyroid carcinoma, high thyroglobulin level, and negative ¹³¹I scan: review of the literature.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Positron emission tomography in non-medullary thyroid cancer.
Topics: Biomarkers, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin | 2011 |
The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2011 |
Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2011 |
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiometry; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
[Diagnostic strategy of incidental findings of focal thyroid FDG uptake identified on PET/CT].
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2011 |
Molecular imaging in the management of thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
PET/CT imaging of thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Thyroid incidentaloma.
Topics: Adult; Aging; Biopsy, Fine-Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Ultrasonography | 2012 |
How has the management of medullary thyroid carcinoma changed with the advent of 18F-FDG and non-18F-FDG PET radiopharmaceuticals.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis.
Topics: Carcinoma, Medullary; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2012 |
The role of nuclear medicine in differentiated thyroid cancer.
Topics: Biomarkers, Tumor; Biopsy, Needle; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radionuclide Imaging; Radiotherapy, Adjuvant; Receptors, Somatostatin; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography; Ultrasonography, Interventional; Whole Body Imaging | 2012 |
Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2012 |
Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.
Topics: Biomarkers, Tumor; Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Positron emission tomography in thyroid cancer management.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2003 |
Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
PET in the follow-up of differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2003 |
FDG PET and alternative imaging in the management of thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Prognosis; Radiography; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Compounds; Thallium; Thyroid Neoplasms | 2004 |
Investigation of thyroid, head, and neck cancers with PET.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2004 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Topics: Carcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2006 |
Workup of well-differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Biopsy, Fine-Needle; Carcinoma, Papillary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Preoperative Care; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.
Topics: Carcinoma, Medullary; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2006 |
[PET in thyroid cancers].
Topics: Adenocarcinoma; Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2006 |
Controversies in the surveillance of patients with well differentiated thyroid cancer.
Topics: Cell Differentiation; Fluorodeoxyglucose F18; Humans; Population Surveillance; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2007 |
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2007 |
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Topics: Carcinoma, Medullary; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Whole Body Imaging | 2007 |
[Utility of positron emission tomography with fluorodeoxyglucose (FDG-PET) in the evaluation of thyroid cancer: a systematic review].
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2007 |
Distant metastases of differentiated thyroid cancer: diagnosis, treatment and outcome.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Practice Patterns, Physicians'; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2007 |
Nuclear medicine in the assessment of differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Positron-Emission Tomography; Radionuclide Imaging; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Role of PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2008 |
PET imaging in endocrine tumours.
Topics: Adrenal Gland Neoplasms; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neck; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer.
Topics: Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
Topics: Carcinoma; Carcinoma, Medullary; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperparathyroidism; Iodine Radioisotopes; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Parathyroid Hormone; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Radiation myelopathy with partial functional recovery: PET evidence of long-term increased metabolic activity of the spinal cord.
Topics: Adult; Atrophy; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Methionine; Neoplasm Staging; Oxygen Radioisotopes; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Detection of residual and recurrent thyroid cancer by radionuclide imaging.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1999 |
[PET evaluation of glucose metabolism in cancer].
Topics: Cancer Care Facilities; Costs and Cost Analysis; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Glucose; Humans; Japan; Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[Progress of nuclear oncology].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Radionuclide Imaging; Technetium; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Radiopharmaceuticals; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
The role of F-18FDG PET in thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2000 |
Nuclear medicine imaging procedures in differentiated thyroid carcinoma patients with negative iodine scan.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms | 2000 |
The indications of FDG-PET in neck oncology.
Topics: Carcinoma, Squamous Cell; Equipment Design; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography of the thyroid, with an emphasis on thyroid cancer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Staging; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hürthle cell thyroid cancer.
Topics: Adenoma, Oxyphilic; Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Male; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
53 trial(s) available for fluorodeoxyglucose f18 and Thyroid Neoplasms
Article | Year |
---|---|
Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Transplantation; Living Donors; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Diffusion-weighted MRI is not superior to FDG-PET/CT for the detection of neck recurrence in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Whole Body Imaging; Young Adult | 2019 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
Relationship between the immunohistochemistry of the primary tumour and 18F-FDG-PET/CT at recurrence in patients with well-differentiated thyroid carcinoma.
Topics: Cluster Analysis; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2013 |
Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake.
Topics: Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2013 |
Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Young Adult | 2014 |
Prospective evaluation of (68)Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative (131)I-whole body scan: comparison with (18)F-FDG PET-CT.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Precision Medicine; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2014 |
Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results.
Topics: Adult; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2015 |
Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
Topics: Adult; Biomarkers; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2015 |
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2016 |
The influence of I-131 therapy on FDG uptake in differentiated thyroid cancer.
Topics: Adult; Aged; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2008 |
The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
F-18 FDG-PET/CT evaluation of patients with differentiated thyroid cancer with negative I-131 total body scan and high thyroglobulin level.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid c
Topics: Adenocarcinoma, Papillary; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2010 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
Topics: Adolescent; Adult; Aged; Cytological Techniques; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Histological Techniques; Humans; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Unnecessary Procedures; Young Adult | 2011 |
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
First experience with proteasome inhibitor treatment of radioiodine nonavid thyroid cancer using bortezomib.
Topics: Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Quality of Life; Thyroid Neoplasms; Treatment Failure | 2012 |
Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2012 |
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2012 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
18F-FDG PET of patients with Hürthle cell carcinoma.
Topics: Adenoma, Oxyphilic; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2004 |
Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sodium; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Treatment Outcome; Whole-Body Counting | 2004 |
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2004 |
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
Topics: Adult; Aged; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Heterocyclic Compounds; Humans; Male; Metabolic Clearance Rate; Middle Aged; Octreotide; Peptides, Cyclic; Positron-Emission Tomography; Protein Binding; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2005 |
Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2006 |
Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Treatment Failure | 2006 |
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Care; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Treatment Outcome | 2007 |
Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Mas; Pyrimidines; Survival Analysis; Thyroid Neoplasms | 2007 |
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Carcinoembryonic Antigen; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Prospective Studies; Radioimmunodetection; Radioimmunotherapy; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neck; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2008 |
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.
Topics: Adult; Aged; Algorithms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1997 |
An evaluation of FDG-PET in the detection and differentiation of thyroid tumours.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reference Values; Thyroid Hormones; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Radiopharmaceuticals; Stomach Neoplasms; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography.
Topics: Carcinoma, Medullary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.
Topics: Adult; Age Factors; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sex Factors; Survival Analysis; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer.
Topics: Adult; Calcitonin; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Radiography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2000 |
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroid Neoplasms; Thyrotropin; Thyroxine | 2002 |
Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Stimulation, Chemical; Thyroid Neoplasms; Thyrotropin; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
607 other study(ies) available for fluorodeoxyglucose f18 and Thyroid Neoplasms
Article | Year |
---|---|
High-resolution positron emission microscopy of patient-derived tumor organoids.
Topics: Adult; Aged; Animals; Electrons; Fluorodeoxyglucose F18; Glucose; HEK293 Cells; Humans; Microscopy; Middle Aged; Organoids; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tumor Microenvironment | 2021 |
Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
Topics: Adult; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thrombosis; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2022 |
A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Graves Ophthalmopathy; Humans; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2022 |
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival.
Topics: Adenocarcinoma; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Quality of Life; Retrospective Studies; Thyroid Neoplasms | 2022 |
Solitary Nasopharyngeal Metastasis From Papillary Thyroid Carcinoma Shown on FDG PET/CT.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Nasopharyngeal Neoplasms; Nasopharynx; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2022 |
Radioiodine Uptake in Incidentally Detected Neuroendocrine Tumor: Correlative Imaging With FDG PET/CT and 68 Ga-DOTATATE PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2022 |
FDG PET/CT in differentiated thyroid cancer patients with low thyroglobulin levels.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms | 2022 |
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Thyroglobulin; Thyroid Neoplasms | 2022 |
I-PET score: Combining whole body iodine and
Topics: Fluorodeoxyglucose F18; Humans; Iodine; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2023 |
Value of diffusion MRI versus [18F]FDG PET/CT in detection of cervical nodal metastases in differentiated thyroid cancer patients.
Topics: Adenocarcinoma; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2022 |
[
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2023 |
The FDG Pattern of Autonomously Functioning Thyroid Nodules Correlates With Thyroid-Stimulating Hormone and Histopathology.
Topics: Adenoma; Aged; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hyperplasia; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin | 2023 |
Reversing "Flip-Flop" Phenomenon of 131 I and Glucose Avidity in RET-Fusion Positive Radioiodine-Refractory Thyroid Cancer Lesions After Treatment of Pralsetinib.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins c-ret; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Preoperative stratification of cytologically indeterminate thyroid nodules by [
Topics: Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule | 2023 |
Can 99 Tc m -3PRGD 2 (α ν β 3 ) and 18 F-FDG dual-tracer molecular imaging change the therapeutic strategy for progressive refractory differentiated thyroid cancer: Case report.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Molecular Imaging; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2023 |
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphocytes; Neutrophils; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms | 2023 |
Use of
Topics: Animals; Cat Diseases; Cats; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Percutaneous cryoablation of follicular thyroid carcinoma metastasis to the pancreas
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Cryosurgery; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Pancreas; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2023 |
Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
Topics: Clinical Relevance; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Thyroid Neoplasms | 2023 |
Utility of non-contrast Dual Energy Computed Tomography in diagnosis of differentiated thyroid cancer - two case study.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2023 |
Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnets; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Correlation between metabolic uptake of F-18-FDG-PET/computed tomography and thyroglobulin level in differentiated thyroid cancer patients with suspected recurrence.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Thyroglobulin; Thyroid Neoplasms | 2023 |
Predicting
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Neural Networks, Computer; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Thyroid Nodule | 2023 |
Clinical role of 18F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
FDG uptake reflects an immune-enriched subtype of thyroid cancer: Clinical implications of imaging-based molecular characterization.
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Microenvironment | 2023 |
68 Ga-FAPI-Avid Submental Ectopic Papillary Thyroid Carcinoma and Lateral Neck Lymphadenopathy With Low 18 F-FDG Uptake.
Topics: Adult; Biological Transport; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphadenopathy; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Langerhans Cell Histiocytosis With Thyroid Involvement on 18 F-FDG PET/MR.
Topics: Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Infant; Neck; Thyroid Neoplasms | 2023 |
Unilateral Chronic Parotitis With 68 Ga-DOTA-FAPI-04 PET/CT and 18 F-FDG PET/CT Imaging in a Case of a Patient With Papillary Thyroid Carcinoma.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Male; Parotitis; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma.
Topics: Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2020 |
Selective Internal Radiation Therapy for Liver Metastasis of Papillary Thyroid Carcinoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Yttrium Radioisotopes | 2020 |
Topics: Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2020 |
Isolated involvement of thyroid gland by IgG4-related disease revealed by
Topics: Fluorodeoxyglucose F18; Humans; Immunoglobulin G4-Related Disease; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2020 |
Targeting Integrins with Radiolabeled RGD Analogues for Radiotheranostics of Metastatic Radioactive Iodine Nonresponsive Thyroid Cancer: New Avenues in Personalized Medicine.
Topics: Fluorodeoxyglucose F18; Humans; Integrins; Iodine Radioisotopes; Oligopeptides; Precision Medicine; Prospective Studies; Theranostic Nanomedicine; Thyroid Neoplasms | 2020 |
Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Whole Body Imaging | 2020 |
Impact of FDG-PET on therapy management and outcome of differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome | 2020 |
[Frequency of malignancy in thyroid incidentalomas detected by whole body 18F-FDG PET/CT].
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Thyroid Nodule | 2020 |
Isolated Metastasis to Spleen-Stomach Space From Follicular Thyroid Cancer Combined With a Benign Subcutaneous Nodule on 18F-FDG PET/CT and 131I Scintigraphy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Spleen; Stomach; Thyroid Neoplasms; Whole Body Imaging | 2021 |
Cutaneous incidentaloma revealed by [
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin; Thyroid Neoplasms | 2021 |
Thyroid Metastasis From Cutaneous Melanoma on an 18F-FDG PET/CT Study.
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Neoplasms | 2020 |
Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Topics: Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2021 |
RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Survival Analysis; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Gland; Thyroid Neoplasms; Ukraine; Whole-Body Counting | 2020 |
Metastatic cervical lymph nodes from incidental thyroid cancer mimicking lymphomatous involvement on 18F-FDG PET/CT images.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms | 2021 |
Follicular Thyroid Carcinoma Metastases on Round Ligament of Liver.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Round Ligament of Liver; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2021 |
Comparison of
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2021 |
Follicular Thyroid Carcinoma with Unusual Radioiodine-Refractory Breast Metastasis Mimicking Primary Breast Malignancy.
Topics: Adenocarcinoma, Follicular; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Thyroglobulin; Thyroid Neoplasms | 2021 |
Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neck Dissection; Pancreatic Neoplasms; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Whole Body Imaging | 2021 |
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Quinolines; Survival Rate; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2021 |
Thyroid incidentalomas with increased focal
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms | 2021 |
Diffusely increased
Topics: Fluorodeoxyglucose F18; Humans; Hyperthyroidism; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Thyroid Neoplasms | 2022 |
68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Quinolines; Thyroid Neoplasms | 2021 |
Synchronous thyroid cancer on the edge: Incidentalomas of 18F-FDG PET/CT in clinical practice.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms | 2021 |
Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiofrequency Ablation; Thyroid Gland; Thyroid Neoplasms | 2021 |
Liver metastases from medullary thyroid carcinoma detected on
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Thyroid Neoplasms | 2021 |
PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.
Topics: Adenocarcinoma; Adult; Antigens, Surface; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glutamate Carboxypeptidase II; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Neoplasms | 2021 |
Evaluation of the usefulness of positron emission tomography with [18F]fluorodeoxylglucose performed to detect non-radioiodine avid recurrence and/or metastasis of differentiated thyroid cancer - a preliminary study.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms | 2021 |
Application of Pet-CT Fusion Deep Learning Imaging in Precise Radiotherapy of Thyroid Cancer.
Topics: Deep Learning; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2021 |
Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Preoperative Care; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tumor Burden; Young Adult | 2017 |
[18F-FDG-PET/CT showing a thyroid incidentaloma in a patient with thyroid cancer].
Topics: Adenocarcinoma, Follicular; Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2017 |
"Pseudo-progression" in advanced thyroid cancer in response to kinase inhibitor therapy.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin | 2017 |
18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst.
Topics: Aged; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Thyroglossal Cyst; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2017 |
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2017 |
Endotracheal Leiomyoma Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Papillary Thyroid Carcinoma.
Topics: Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Positron Emission Tomography Computed Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tracheal Neoplasms | 2017 |
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography | 2017 |
Thyroid Metastasis as First Manifestation of a Colon Adenocarcinoma With KRAS Mutation: Usefulness of 18F-FDG PET/CT.
Topics: Adenocarcinoma; Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mutation; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Thyroid Neoplasms | 2017 |
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms | 2017 |
Is the 18F-FDG PET/CT the definite resource to detect the recurrence on high-risk thyroid cancer patients?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2017 |
High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2017 |
Oncocytoma: A Differential Consideration for an Incidentally Detected FDG-Avid Renal Mass on PET/CT.
Topics: Adenoma, Oxyphilic; Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Neoplasms; Laparoscopy; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2017 |
Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2018 |
Rare Case of Intratracheal Metastasis Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan in a Case of Thyroglobulin Elevated Negative Iodine Scan Syndrome.
Topics: Biopsy; Carcinoma, Papillary; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Thyroglobulin; Thyroid Neoplasms; Tracheal Neoplasms | 2018 |
Glucose uptake evaluated by 18F-fluorodeoxyglucose positron emission tomography in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Topics: Adenocarcinoma, Follicular; Fluorodeoxyglucose F18; Glucose; Humans; Medical Overuse; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Iodine/FDG "Flip-Flop" Phenomenon Inside a Large Metastatic Thyroid Cancer Lesion Better Characterized on SPECT/CT and PET/CT Studies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2018 |
Functional visceral fat activity evaluated by preoperative F-18 FDG PET/CT predicts regional lymph node metastasis in differentiated thyroid cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Subcutaneous Fat; Thyroid Neoplasms | 2018 |
Isolated solitary recurrent skull metastasis in papillary thyroid carcinoma.
Topics: Adult; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Skull; Thyroglobulin; Thyroid Neoplasms | 2018 |
Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Postoperative Period; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2018 |
Thyroid Incidentalomas Detected on
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk; Risk Assessment; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography | 2018 |
Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
Topics: Adenocarcinoma; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography; Young Adult | 2018 |
Progression of Focal to Diffuse Thyroid Uptake Detected by 18F-FDG PET/CT: Malignant Metastatic Disease or Benign Thyroiditis?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroiditis | 2018 |
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas.
Topics: Adult; Aged; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Iodine Radioisotopes; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; RNA, Messenger; Symporters; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Unusual Presentation of Hurthle Cell Carcinoma With TENIS Syndrome as Left Atrial Thrombus on 18F-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adult; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Iodine Radioisotopes; Positron Emission Tomography Computed Tomography; Thrombosis; Thyroglobulin; Thyroid Neoplasms | 2018 |
Correlation of 18F-FDG uptake and thyroid cancer stem cells.
Topics: AC133 Antigen; Biological Transport; Cell Differentiation; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Indium Radioisotopes; Neoplastic Stem Cells; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Thyrotropin; RNA, Messenger; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Trefoil Factor-1 | 2020 |
Early prediction of lenvatinib treatment efficacy by using
Topics: Adult; Antineoplastic Agents; Clinical Protocols; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Gland; Thyroid Neoplasms; Treatment Failure; Treatment Outcome | 2018 |
Thyroid Metastasis From Hepatocellular Carcinoma Visualized by 18F-FDG PET/CT Imaging.
Topics: Adult; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Hounsfield unit value has null effect on thyroid nodules at 18F-FDG PET/CT scans.
Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2018 |
A Cardiac Metastasis of Follicular Thyroid Carcinoma With Partly Squamous Cell Differentiation: Detection in FDG-PET Preceded Visibility on Echocardiography and MRI by More Than a Year.
Topics: Adenocarcinoma, Follicular; Carcinoma, Squamous Cell; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
18F-FDG PET/CT of Squamous Cell Carcinoma in a Thyroglossal Duct Cyst.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroglossal Cyst; Thyroid Neoplasms | 2019 |
Ectopic Papillary Thyroid Carcinoma Mimicking Esophageal Cancer in FDG PET: A Case Report.
Topics: Adult; Carcinoma, Papillary; Choristoma; Diagnosis, Differential; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2019 |
Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pituitary Gland; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Thyrotropin | 2019 |
Thyroid incidentaloma as a "PAIN" phenomenon- does it always require surgery?
Topics: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms | 2018 |
Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Young Adult | 2019 |
Challenges in the treatment of parathyroid carcinoma: a case report.
Topics: Adult; Bone Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism, Primary; Jaw Diseases; Neoplasms, Multiple Primary; Osteolysis; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Thyroid metastasis from breast cancer detected by 18F-FDG PET/CT.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
OCCUPATIONAL RADIATION DOSE TO NUCLEAR MEDICINE STAFF DUE TO TC99M, F18-FDG PET AND THERAPEUTIC I-131 BASED EXAMINATIONS.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Middle Aged; Nuclear Medicine; Occupational Exposure; Positron-Emission Tomography; Prognosis; Radiation Dosage; Radiation Exposure; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thyroid Neoplasms | 2019 |
Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Factors; Survival Analysis; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Merkel cell carcinoma: an aggressive cutaneous carcinoma with rare metastasis to the thyroid gland.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Merkel Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Gland; Thyroid Neoplasms | 2019 |
FDG-Avid Hürthle Cell Thyroid Adenoma.
Topics: Adenoma, Oxyphilic; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Oxyphil Cells; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
Risk of Malignancy in FDG-Avid Thyroid Incidentalomas on PET/CT: A Prospective Study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy, Fine-Needle; Denmark; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Risk; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography | 2019 |
Cystic form of cervical lymphadenopathy. Guidelines of the French Society of Otorhinolaryngology - Head and Neck Surgery (SFORL). Part 1: Diagnostic procedures for lymphadenopathy in case of cervical mass with cystic aspect.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image-Guided Biopsy; Lymphadenopathy; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cell Differentiation; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Young Adult | 2019 |
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Time Factors | 2013 |
Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Topics: Adult; Aged; Chi-Square Distribution; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Response to stack et Al.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2013 |
Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Topics: Adult; Aged; Antibodies; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2013 |
Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A; Young Adult | 2013 |
18-fluorodeoxyglucose positron emission tomography in the early diagnostic workup of differentiated thyroid cancer patients with a negative post-therapeutic iodine scan and detectable thyroglobulin.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2013 |
Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiation Dosage; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Metabolic response demonstrated by 18F-FDG-PET/CT in metastatic medullary thyroid carcinoma under sorafenib therapy.
Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Sorafenib; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Mammography; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms; Ultrasonography, Mammary | 2013 |
Unusual muscular metastases from papillary thyroid carcinoma detected by fluorine-18-fluorodeoxyglucose PET/MRI.
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Unnecessary Procedures | 2013 |
Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
PET/ultrasound fusion for differentiation of Vox implant silicone particles from recurrent cancer.
Topics: Artifacts; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostheses and Implants; Radiopharmaceuticals; Silicones; Subtraction Technique; Thyroid Neoplasms; Ultrasonography | 2013 |
Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyrotropin Alfa | 2013 |
Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Risk; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2013 |
Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis?
Topics: Aged; Aged, 80 and over; Chronic Disease; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Thyroid Gland; Thyroid Neoplasms; Thyroiditis; Tomography, X-Ray Computed | 2013 |
Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Topics: Adenocarcinoma, Papillary; Adult; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Evaluation of rare choroid plexus metastasis from papillary thyroid carcinoma with multimodality imaging.
Topics: Carcinoma; Carcinoma, Papillary; Choroid Plexus Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
[Diagnostic values of ultrasound and (18)F-fluoro-2-deoxy-D-glucose-positron emission tomography/computerized tomography for patients with suspected thyroid carcinoma and lymph node metastasis].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
68Ga-dotatate avid medullary thyroid cancer with occult liver metastases.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Thyroid Neoplasms | 2014 |
Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.
Topics: Adolescent; Adult; Aged; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Positron-Emission Tomography; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Small cell carcinoma of the thyroid gland with a solid brain metastasis detected by F-18-FDG PET/CT.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Thyroid Neoplasms | 2014 |
The added clinical value of 18F-FDG PET/CT in evaluating intratracheal recurrence of differentiated thyroid carcinoma: implications for planning surgery, assessing its completeness, and planning radioiodine therapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms; Tomography, X-Ray Computed; Trachea | 2013 |
The difference in relationship between 18F-FDG uptake and clinicopathological factors on thyroid, esophageal, and lung cancers.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Radionuclide Imaging; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2014 |
Relationship between positive thyroglobulin doubling time and 18F-FDG PET/CT-positive, 131I-negative lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
Left atrial metastasis of Hürthle-cell thyroid carcinoma mimicking myxoma.
Topics: Adenoma, Oxyphilic; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Myxoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
Topics: Adenocarcinoma, Follicular; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thailand; Thyroid Neoplasms; Whole Body Imaging | 2013 |
Diagnostic value of 18F-FDG PET/CT in patients with TENIS syndrome: correlation with thyroglobulin levels.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Syndrome; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2014 |
Incidental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological features?
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms | 2014 |
Pleural metastases from papillary thyroid carcinoma mimicking mesothelioma.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Diagnosis, Differential; Fatal Outcome; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
Topics: Adenocarcinoma, Follicular; Age Factors; Aged; Algorithms; Biomarkers, Tumor; Biopsy, Fine-Needle; Diagnosis, Differential; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Risk Adjustment; Risk Factors; Sensitivity and Specificity; Sex Factors; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2014 |
Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Topics: Asymptomatic Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Complete and partly unexpected diagnostic findings at 18F-FDG-PET/CT scanning in patients with suspected prosthetic valve endocarditis.
Topics: Aged; Anti-Bacterial Agents; Combined Modality Therapy; Echocardiography, Transesophageal; Endocarditis, Bacterial; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Streptococcal Infections; Streptococcus anginosus; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Tonsillitis | 2014 |
Intraluminal Superior Vena Cava Metastasis in a Patient With Poorly Differentiated Thyroid Carcinoma.
Topics: Adenocarcinoma; Aged; Cough; Deglutition Disorders; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Respiratory Sounds; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Vascular Neoplasms; Vena Cava, Superior | 2015 |
¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Topics: Adult; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Fluorodeoxyglucose F18; Health Care Costs; Humans; Markov Chains; Models, Econometric; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2014 |
Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients.
Topics: Algorithms; Australia; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy | 2015 |
Clinical value of visually identifiable 18F-fluorodeoxyglucose uptake in primary papillary thyroid microcarcinoma.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Papillary; Chi-Square Distribution; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Logistic Models; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult | 2014 |
Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Diffuse metastasis to the thyroid: unique ultrasonographic finding and clinical correlation.
Topics: Aged; Bile Duct Neoplasms; Biopsy, Fine-Needle; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Lung Neoplasms; Male; Middle Aged; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Function Tests; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2014 |
Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan.
Topics: Adenoma, Oxyphilic; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2015 |
Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Fine-Needle; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2014 |
Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131Iodine-avid lung metastasis from differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Analysis; Thyroid Neoplasms | 2014 |
Primary squamous cell carcinoma of the thyroid on FDG PET/CT.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Rebound thymic hyperplasia detected by 18F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer.
Topics: Ablation Techniques; Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Retrospective Studies; Thymus Hyperplasia; Thyroid Neoplasms; Tomography, Emission-Computed; Young Adult | 2014 |
A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice.
Topics: Animals; Body Weight; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Reproducibility of Results; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; X-Ray Microtomography | 2015 |
Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
Topics: Adult; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Cervix carcinoma and incidental finding of medullary thyroid carcinoma by 18F-FDG PET/CT--clinical case.
Topics: Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2014 |
The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
Topics: Adult; Aged; Autoantibodies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2014 |
Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Positron emission tomography-positive thyroid nodules: rate of malignancy and histological features.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2016 |
Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Topics: Biological Transport; Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reference Standards; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
Lesionalized therapy beyond personalized therapy in cancer management.
Topics: Fluorodeoxyglucose F18; Genetic Variation; Humans; Iodine Radioisotopes; Molecular Imaging; Positron-Emission Tomography; Precision Medicine; Symporters; Thyroid Neoplasms; Tumor Microenvironment | 2014 |
Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm, Residual; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Multimodal Imaging; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2015 |
Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Thyroid Nodule | 2015 |
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
ACR white paper targets thyroid incidentaloma reporting.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Periodicals as Topic; Publications; Research Report; Thyroid Neoplasms | 2015 |
(18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Treatment Outcome | 2015 |
FDG PET performed at thyroid remnant ablation has a higher predictive value for long-term survival of high-risk patients with well-differentiated thyroid cancer than radioiodine uptake.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Differentiation; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Function Tests; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT.
Topics: Aged; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
F-18 FDG PET/CT imaging in the diagnostic work-up of thyroid cancer patients with high serum thyroglobulin, negative I-131 whole body scan and suppressed thyrotropin: 8-year experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2015 |
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection.
Topics: Carcinoma, Papillary; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Radionuclide Imaging; Syphilis; Thyroid Neoplasms; Thyroidectomy; Viral Load | 2015 |
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mutation; Neoplasm Staging; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Prognostic value of (18)F-FDG PET/CT metabolic parameters in metastatic differentiated thyroid cancers.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Papillary; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Diseases; Thyroid Neoplasms | 2016 |
Prognostic role of FDG-PET/CT in differentiated thyroid carcinoma: Where are we now?
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Thyroid carcinoma detected by incidental (18)F-FDG uptake in a patient with progressive cerebellar syndrome.
Topics: Carcinoma; Carcinoma, Papillary; Cerebellar Diseases; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed | 2016 |
High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2016 |
Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Octreotide; Organometallic Compounds; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms | 2015 |
SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2015 |
18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Thyroid Cartilage; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Disease Management; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Hyperthyroidism; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2015 |
The role of early 18F-FDG PET/CT in therapeutic management and ongoing risk stratification of high/intermediate-risk thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Whole Body Imaging; Young Adult | 2016 |
Intrathoracic Benign Goiter Imaged by 18F-FDG-PET: A Case Report.
Topics: Adenoma; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; X-Rays | 2015 |
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2016 |
Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Retrospective Studies; Risk; Risk Assessment; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Hypometabolic Lateral Recti Due to Bilateral Cranial Nerve VI Palsy.
Topics: Abducens Nerve Diseases; Carcinoma; Carcinoma, Papillary; Esotropia; Fluorodeoxyglucose F18; Humans; Middle Aged; Oculomotor Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2015 |
SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Retrospective Studies; Risk Factors; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2015 |
[(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2016 |
A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma; Carcinoma, Papillary; Color; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Burden | 2015 |
Activation of brown adipose tissue in hypothyroidism.
Topics: Adipose Tissue, Brown; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Body Temperature; Case-Control Studies; Child; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Male; Middle Aged; Positron-Emission Tomography; Rats; Rats, Wistar; Retrospective Studies; Temperature; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Young Adult | 2015 |
Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutamic Acid; Humans; Immunohistochemistry; Male; Middle Aged; Mutation, Missense; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed; Valine; Young Adult | 2016 |
Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mutation; Neoplasm Staging; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Sex Factors; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2015 |
Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Circulating epithelial cell enumeration facilitates the identification and follow-up of a patient with early stage papillary thyroid microcarcinoma: A case report.
Topics: Adult; Carcinoma, Papillary; Cell Count; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2016 |
Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Somatostatin; Technetium Tc 99m Sestamibi; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2016 |
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Survival Rate; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2016 |
Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2016 |
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?
Topics: Acetates; Antigens, Surface; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Ethylenediamines; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Ultrasonography | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Letter to the Editor Regarding the Article "(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis".
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2016 |
18F-FDG PET Detection of a Medullary Thyroid Carcinoma in a Patient With SMZL.
Topics: Aged, 80 and over; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Positron Emission Tomography Computed Tomography; Splenic Neoplasms; Thyroid Neoplasms | 2016 |
Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
Topics: Adolescent; Adult; Age Factors; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2016 |
Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.
Topics: Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2016 |
Grouping of Metastatic Thyroid Carcinoma by Molecular Imaging Features to Allow for Individualized Treatment, with Emphasis on the TENIS Syndrome.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Precision Medicine; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2016 |
The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2016 |
The incidence of 18F-FDG PET/CT thyroid incidentalomas andthe prevalence of malignancy: a prospective study.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Positron Emission Tomography Computed Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2016 |
Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tumor Burden; Young Adult | 2016 |
Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
Topics: Adult; Aged; Biological Transport; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2016 |
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thyroid Neoplasms | 2016 |
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2016 |
Ultrasound findings of diffuse metastasis of gastric signet-ring-cell carcinoma to the thyroid gland.
Topics: Aged; Biopsy, Fine-Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms; Ultrasonography, Doppler, Color | 2017 |
Variable Cold-Induced Brown Adipose Tissue Response to Thyroid Hormone Status.
Topics: Adipose Tissue, Brown; Adult; Carcinoma, Papillary; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Thermogenesis; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotoxicosis; Young Adult | 2017 |
Differences in Brain Glucose Metabolism During Preparation for
Topics: Adult; Affect; Anxiety; Brain; Cognition; Cross-Sectional Studies; Depression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 2017 |
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2017 |
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms | 2016 |
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2017 |
Multiple Endocrine Neoplasia Type 2B Unmasked by 18 F-FDG PET/CT and 131 I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multiple Endocrine Neoplasia Type 2b; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2017 |
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Fluorodeoxyglucose F18; Foscarnet; Humans; Positron Emission Tomography Computed Tomography; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2017 |
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Molecular Targeted Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Thyroid Neoplasms | 2017 |
Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
Topics: Adolescent; Adult; Aged; Biological Transport; Carcinoma; Carcinoma, Papillary; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2017 |
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2008 |
The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
Topics: Carcinoma; Cell Differentiation; Contrast Media; DNA; Fluorodeoxyglucose F18; Humans; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Topics: Adenocarcinoma; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2008 |
Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Logistic Models; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thyroid Neoplasms; Tomography, Emission-Computed; Ultrasonography, Interventional | 2008 |
Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
Topics: Adult; Aged; Carbon Radioisotopes; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methionine; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2008 |
FDG-PET for a thyroid MALT lymphoma.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Diagnosis of poorly differentiated thyroid cancer with radioiodine scanning after thyrotropin alfa stimulation.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Glycoprotein Hormones, alpha Subunit; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed | 2008 |
Current role of radionuclide imaging in differentiated thyroid cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2008 |
Synchronicity.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiography; Scalp; Skin Neoplasms; Thyroid Neoplasms | 2008 |
Thyroid lymphoma: early clinical suspicion may be critical for cure.
Topics: Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Lymphoma; Thyroid Neoplasms | 2008 |
Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma.
Topics: Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Sensitivity and Specificity; Surgery, Computer-Assisted; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed; Young Adult | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Metastatic colorectal cancer to a primary thyroid cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms | 2008 |
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Pre-therapy hyperfunctioning follicular thyroid carcinoma evaluation with I-131 whole-body scan and with F-18 FDG PET/CT.
Topics: Adenocarcinoma, Follicular; Aged; Fluorodeoxyglucose F18; Glycolysis; Humans; Hyperthyroidism; Iodine Radioisotopes; Male; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
Topics: Adult; Aged; Biomarkers; Cancer Care Facilities; Carcinoma, Papillary; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ontario; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Time Factors; Treatment Outcome; Young Adult | 2008 |
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Fluorodeoxyglucose F18; Genetic Variation; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, X-Ray Computed | 2009 |
Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
Topics: Adenocarcinoma, Follicular; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyrotropin; Tumor Cells, Cultured | 2009 |
Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Topics: Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
A patient with micropapillary thyroid carcinoma and macronodular lung metastasis: stable disease for eight years without treatment.
Topics: Biopsy, Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Neck Dissection; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2009 |
The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Young Adult | 2009 |
F-18 FDG-avid intrathyroidal parathyroid adenoma mimicking follicular neoplasm.
Topics: Adenoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms | 2009 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Young Adult | 2009 |
Follicular thyroid carcinoma with an eggshell calcification: report of 3 cases.
Topics: Adenocarcinoma, Follicular; Aged; Biopsy, Needle; Bone Neoplasms; Calcinosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Ultrasonography, Doppler, Color | 2009 |
Nodal metastasis from occult thyroid cancer detected by FDG PET-CT in a patient with 2 known malignancies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prostatic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Anatomic and metabolic imaging of venous thromboembolism mimicking thyroid carcinoma extension.
Topics: Adenocarcinoma, Follicular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Venous Thromboembolism | 2010 |
Evaluation of 18fluoro-2-deoxyglucose positron emission tomography in iodine scan negative, differentiated thyroid cancer recurrence.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging; Young Adult | 2009 |
[Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination].
Topics: Breast Neoplasms; Colonic Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Mass Screening; Occult Blood; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-ras.
Topics: Adenoma; Cell Line, Tumor; Enzyme Activation; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mutation; Radionuclide Imaging; Radiopharmaceuticals; ras Proteins; Thyroid Neoplasms | 2009 |
Follicular thyroid adenoma with eggshell calcification presenting as an intensely hypermetabolic lesion on 18F-FDG PET/CT.
Topics: Adenoma; Aged; Calcinosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthyroidism; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2010 |
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.
Topics: Bone Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Disease Susceptibility; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2010 |
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Calcinosis; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Leukocytes; Lymph Nodes; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Analysis; Taiwan; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
Topics: Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Recurrence; Thyroid Neoplasms | 2010 |
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Child; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Hormone Replacement Therapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Recombinant Proteins; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Young Adult | 2010 |
Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mutation; Pancreatic Neoplasms; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2010 |
Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy: the usefulness of F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Child; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radionuclide Imaging; Recurrence; Statistics, Nonparametric; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome; Ultrasonography; Whole Body Imaging | 2010 |
Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Intraoperative radiation exposure with the use of (18)F-FDG-guided thyroid cancer surgery.
Topics: Fluorodeoxyglucose F18; Humans; Intraoperative Period; Minimally Invasive Surgical Procedures; Occupational Exposure; Pilot Projects; Positron-Emission Tomography; Radiation Monitoring; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Thyroid Neoplasms; Treatment Outcome | 2010 |
High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up.
Topics: Adult; Age Factors; Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Health; Humans; Incidence; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Time Factors | 2010 |
Comparison of positron emission tomography with [(18)F]FDG and [(68)Ga]DOTATOC in recurrent differentiated thyroid cancer: preliminary data.
Topics: Adult; Aged; Aged, 80 and over; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2010 |
FDG avid supraclavicular neck adenopathy of tubercular etiology masquerading as neck recurrence in differentiated thyroid carcinoma: potential source of false positive FDG-PET study.
Topics: Adolescent; Carcinoma, Papillary; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2010 |
[Management of thyroid cancers and nodules: what's new].
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule | 2010 |
Subacute thyroiditis presenting as a focal lesion on [18F] fluorodeoxyglucose whole-body positron-emission tomography/CT.
Topics: Biopsy, Fine-Needle; Diagnosis, Differential; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Severity of Illness Index; Thyroid Neoplasms; Thyroiditis, Suppurative; Tomography, X-Ray Computed | 2011 |
Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2010 |
Renal metastasis from Hurthle cell thyroid carcinoma and its evaluation with hybrid imaging.
Topics: Adenocarcinoma, Follicular; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms | 2010 |
Detection of papillary thyroid cancer brain metastasis with FDG-PET/CT.
Topics: Aged; Brain Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Regression Analysis; Retrospective Studies; Risk Factors; Thyroid Neoplasms | 2010 |
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2011 |
Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET.
Topics: Adult; Breast Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroid Neoplasms; Whole Body Imaging | 2010 |
Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Relationship between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in incidentally detected thyroid cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Carbonic Anhydrase IX; Carbonic Anhydrases; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Vascular Endothelial Growth Factor A | 2010 |
Imaging features in a rare case of MALTOMA of the thyroid.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2010 |
The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Genotype; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms; Young Adult | 2010 |
18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Papillary; Contrast Media; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Male; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation.
Topics: Biological Transport; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Incidental Findings; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; ROC Curve; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2010 |
Follicular variant of papillary thyroid carcinoma presenting as a toxic nodule by I-123 scintigraphy.
Topics: Carcinoma; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Renal cell carcinoma presenting as isolated thyroid metastasis 13 years after radical nephrectomy, detected on F-18 FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nephrectomy; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Young Adult | 2010 |
Metastatic colon carcinoma in a preexisting thyroid nodule.
Topics: Adenocarcinoma; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2010 |
Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2011 |
Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.
Topics: Adult; Aged; Calcitonin; Carbon Radioisotopes; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2010 |
Fluorodeoxyglucose-avid parathyroid adenoma mimicking thyroid incidentaloma.
Topics: Adenoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Parathyroid Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms | 2010 |
Renal metastases from thyroid carcinoma.
Topics: Adenoma, Oxyphilic; Carcinoma; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Positron-Emission Tomography; Quality of Life; Thyroid Neoplasms | 2010 |
F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2011 |
Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Incidental finding of F-18 FDG skin uptake in a patient with psoriasis during the evaluation of a recurrent papillary thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Recurrence; Skin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Thyroid metastasis from primary renal cell cancer on FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
A letter regarding diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Utility of ¹¹C-choline imaging as a supplement to F-18 FDG PET imaging for detection of thyroid carcinoma.
Topics: Adult; Aged; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Metabolic imaging allows early prediction of response to vandetanib.
Topics: Aged; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Dihydroxyphenylalanine; Down-Regulation; Female; Fluorodeoxyglucose F18; G1 Phase; Glucose; Humans; Male; Mice; Mice, SCID; Microarray Analysis; Piperidines; Positron-Emission Tomography; Proto-Oncogene Proteins c-ret; Quality Control; Quinazolines; Radiopharmaceuticals; Resting Phase, Cell Cycle; RNA, Neoplasm; Signal Transduction; Thymidine; Thyroid Neoplasms; Tomography, Emission-Computed | 2011 |
Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.
Topics: Adult; Biopsy, Fine-Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Ultrasonography | 2011 |
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodies.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2011 |
Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive (131)I whole body scan?
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
PET and PET/CT in the management of thyroid cancer.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms | 2011 |
F-18 FDG PET/CT detecting thyroid plasmacytoma after the successful treatment of gastric large B-cell lymphoma.
Topics: Aged, 80 and over; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Plasmacytoma; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cross-Sectional Studies; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Goiter, Nodular; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Taiwan; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution; Tomography, X-Ray Computed | 2011 |
F18-FDG PET/CT and differentiated thyroid carcinoma: a critical and still debated issue.
Topics: Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transport Proteins, Facilitative; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2011 |
Hepatocellular carcinoma eats medullary thyroid carcinoma, a case of tumor-in-tumor metastasis.
Topics: Carcinoma, Hepatocellular; Carcinoma, Medullary; Fluorodeoxyglucose F18; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Ultrasonography | 2011 |
Comparison of diagnostic and prognostic capabilities of ¹⁸F-FDG-PET/CT, ¹³¹I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2011 |
Simultaneous uptake of I-131 and F-18 FDG by a renal metastasis of thyroid papillary cancer.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2011 |
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Thyroid Neoplasms; Thyroiditis, Autoimmune; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2011 |
Clinical value of integrated [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Precancerous Conditions; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2011 |
Intramedullary spinal cord metastasis from papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Laminectomy; Leg; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Walking; Whole Body Imaging | 2011 |
[Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neck; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome; Whole Body Imaging | 2011 |
Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lung; Lymph Nodes; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
18F-fluorodeoxyglucose and 131I radioguided surgical management of thyroid cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2012 |
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques.
Topics: Adenocarcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
False-positive F-18 FDG PET/CT from foreign body reaction on anterior chest wall after endoscopic total thyroidectomy via axillo-breast approach for thyroid cancer: two case reports.
Topics: Adult; Axilla; Breast; Endoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Foreign-Body Reaction; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thoracic Wall; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2011 |
Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
Topics: Animals; Base Sequence; Biological Transport; Cell Survival; Colony-Forming Units Assay; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genetic Therapy; Hexokinase; Humans; Iodine Radioisotopes; Lentivirus; Mice; RNA Interference; RNA, Messenger; RNA, Small Interfering; Symporters; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2011 |
Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging; Young Adult | 2012 |
General nuclear medicine.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Infections; Multimodal Imaging; Neuroendocrine Tumors; Nuclear Medicine; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
F-18 FDG PET/CT imaging of endogenous Cushing syndrome.
Topics: Carcinoma, Medullary; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
Topics: Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
Topics: Adenocarcinoma; Adult; Autoantibodies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2012 |
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Recurrence; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cell Differentiation; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Iodine Radioisotopes; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Is it possible to predict malignancy in cases with focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography?
Topics: Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Neoplasms; Ultrasonography, Interventional | 2012 |
Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Diseases; Thyroid Neoplasms; Thyroid Nodule; Thyroiditis, Autoimmune; Tomography, X-Ray Computed | 2012 |
Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Isolated cardiac metastasis from papillary thyroid cancer: prolonged survival with late diagnosis related to inadequate positron emission tomography preparation.
Topics: Carcinoma; Carcinoma, Papillary; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Survival; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2012 |
Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2012 |
Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Infant; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression.
Topics: Adult; Aged; Caveolin 1; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; PTEN Phosphohydrolase; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Pioglitazone therapy in progressive differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurre
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
High FDG and low FLT uptake in a thyroid papillary carcinoma incidentally discovered by FDG PET/CT.
Topics: Biological Transport; Carcinoma; Carcinoma, Papillary; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Tracheal Neoplasms | 2012 |
¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Risk; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Failure; Whole Body Imaging; Young Adult | 2012 |
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cisplatin; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Niacinamide; Paclitaxel; Phenylurea Compounds; Piperidines; Pyridines; Pyrroles; Quinazolines; Radiopharmaceuticals; Sorafenib; Sunitinib; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2012 |
[Diagnostics and treatment of differentiated thyroid cancer using nuclear medicine].
Topics: Autoantibodies; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer.
Topics: Adult; Aged; Cohort Studies; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Incidental Findings; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
Topics: Autoantibodies; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2012 |
Comment on Rosenbaum-Krumme et al.: (18)F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2012 |
Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Symporters; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Topics: Adult; Aged; Autoantibodies; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2012 |
Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.
Topics: Biopsy, Fine-Needle; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2013 |
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |
Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET.
Topics: Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Retrospective Studies; Sorafenib; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome | 2013 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult | 2012 |
Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; China; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Technetium Tc 99m Medronate; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Italy; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms | 2013 |
Diagnostic value and therapeutic impact of (18)F-FDG-PET/CT in differentiated thyroid cancer. Results of a German multicentre study.
Topics: Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Focal thyroid uptake on 18F-fluorodeoxyglucose positron emission tomography: interpreting the data.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2013 |
Prevalence and risk of malignancy of thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron-emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2013 |
Response to Treglia et al.
Topics: Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2013 |
Unusual case of isolated parasellar metastasis from carcinoma of thyroid.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pituitary Gland; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Hürthle cell neoplasms: a new differential diagnosis for 18F-FDOPA-avid thyroid nodules?
Topics: Adenoma, Oxyphilic; Adrenal Gland Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms; Thyroid Nodule | 2013 |
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole- body scan and elevated thyroglobulin levels.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole-body scan and elevated thyroglobulin levels.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
[Value of F-18 fluorodeoxyglucose positron emission tomography in thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Adenoma; Carcinoma, Papillary; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Prognosis; Sensitivity and Specificity; Survival Rate; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
How high can the standardized uptake value be?
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Thyroid Neoplasms; Tissue Distribution; Urinary Bladder Neoplasms | 2002 |
[Renal cell carcinoma metastasis in a microfollicular adenoma of the thyroid gland].
Topics: Adenoma; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nephrectomy; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2002 |
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
18F-FDG-PET in the follow-up of thyroid cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Irradiation | 2003 |
Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2003 |
F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Thyroiditis, Autoimmune; Tomography, Emission-Computed | 2003 |
Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.
Topics: Adenoma; Adult; Aged; Austria; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Goiter, Endemic; Humans; Male; Middle Aged; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2003 |
Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2003 |
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 2)].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Quality Assurance, Health Care; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Thyroid Neoplasms; Thyrotropin | 2003 |
[Rapid diagnosis of recurrence of a tall cell variant of papillary thyroid cancer by endogenous TSH stimulation].
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed; Ultrasonography | 2003 |
Increased 18F-FDG uptake mimicking thyroid cancer in a patient with Hashimoto's thyroiditis.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thyroid Neoplasms; Thyroiditis, Autoimmune; Tomography, Emission-Computed | 2003 |
Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
F-18 FDG PET in insular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy.
Topics: Adult; Autopsy; Blood Vessels; Cervical Vertebrae; Demyelinating Diseases; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Medulla Oblongata; Meningitis; Methionine; Nerve Degeneration; Neurons; Oxygen Radioisotopes; Paraplegia; Radiation Injuries; Radiography; Radiotherapy; Spinal Cord; Spinal Cord Diseases; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2003 |
FDG PET imaging in hereditary thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Staging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors.
Topics: Fluorodeoxyglucose F18; Neoplasm Recurrence, Local; Nervous System Neoplasms; Neural Crest; Neuroendocrine Tumors; Patient Care Management; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Combined positron emission tomography - computed tomography improves specificity for thyroid carcinoma by identifying vocal cord activity after laryngeal nerve paralysis.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vocal Cord Paralysis; Vocal Cords | 2003 |
Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
The influence of thyroglobulin on functional imaging in differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
False-positive finding on 18F-FDG PET after chemotherapy for primary diffuse large B-cell lymphoma of the thyroid: a case report.
Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2004 |
Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Chi-Square Distribution; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2004 |
Positron emission tomography in primary thyroid lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2004 |
Intense FDG uptake in a benign Hurthle cell adenoma.
Topics: Adenoma, Oxyphilic; Aged; Fluorodeoxyglucose F18; Humans; Male; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms | 2004 |
[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor.
Topics: Adult; Aged; Animals; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Swine; Thyroid Neoplasms | 2005 |
[Early detection of synchronous thyroid carcinoma and malignant melanoma by fluorodeoxyglucose positron emission tomography].
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms | 2003 |
Physiological uptake of [18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics?
Topics: Adolescent; Adult; Age Distribution; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck; Netherlands; Organ Specificity; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thorax; Thyroid Neoplasms; Tissue Distribution | 2004 |
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
The utility of multimodality imaging in anaplastic thyroid carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2005 |
Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Papillary; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroiditis; Ultrasonography | 2005 |
Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Symporters; Thyroid Neoplasms; Thyrotropin | 2005 |
Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2005 |
Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Radiosurgery; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography | 2005 |
FDG-PET in head and neck, and thyroid cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms | 2005 |
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Topics: Adult; Age Factors; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sex Factors; Survival Analysis; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2006 |
A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neck; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Thyroid Neoplasms; Vincristine | 2005 |
Focal F-18 fluorodexyglucose positron emission tomography uptake in a hyalinized nodule as a false positive splenic metastasis in a patient with breast cancer and metastatic thyroid cancer.
Topics: Aged; Breast Neoplasms; Calcinosis; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Hyalin; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Diseases; Splenic Neoplasms; Thyroid Neoplasms | 2005 |
Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Rectal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2005 |
Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.
Topics: Adenoma, Oxyphilic; Adult; Aged; Carcinoma, Papillary; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surgery, Computer-Assisted; Thyroid Neoplasms; Treatment Outcome | 2005 |
Normal uptake of F-18 FDG in the sublingual gland.
Topics: Carcinoma, Papillary; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Sublingual Gland; Sublingual Gland Neoplasms; Thyroid Neoplasms | 2006 |
Metastatic cancer in thyroid detected by FDG PET.
Topics: Breast Neoplasms; Carcinoma, Ductal; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2006 |
Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thymus Gland; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2005 |
Thyroid-stimulating hormone-stimulated fused positron emission tomography/computed tomography in the evaluation of recurrence in 131I-negative papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2006 |
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adenoma, Oxyphilic; Adult; Aged; Disease Management; Drug Resistance; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Topics: Adult; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Subtraction Technique; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2006 |
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Thyroid Neoplasms; Thyroidectomy | 2006 |
Single F-18 fluorodeoxyglucose positron emission tomography hypermetabolic focus containing metastatic papillary thyroid cancer within a primary scarring adenocarcinoma lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2006 |
[Mediastinal lymph node metastasis of thyroid cancer occurring 15 years after the initial operation; report of a case].
Topics: Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Nuclear Proteins; Positron-Emission Tomography; Postoperative Period; Thyroid Neoplasms; Thyroid Nuclear Factor 1; Thyroidectomy; Transcription Factors | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
Topics: Adult; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Proteins; Radionuclide Imaging; Radiopharmaceuticals; Receptor, Cholecystokinin B; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2006 |
In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-Iodide.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fluorodeoxyglucose F18; Glucose; In Vitro Techniques; Iodine Radioisotopes; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Rats; Signal Transduction; Thyroid Neoplasms; Thyrotropin | 2006 |
99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Positron-Emission Tomography; Somatostatin; Thyroid Neoplasms | 2006 |
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Point Mutation; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Survival Analysis; Thyroid Neoplasms; Thyroidectomy | 2006 |
Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
18F-FDG PET of thyroid nodules with inconclusive cytologic results.
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2006 |
Focal pelvic uptake in 18F-FDG PET due to a contraceptive device; a potential pitfall easily unmasked by PET-CT.
Topics: Adult; Carcinoma, Papillary; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intrauterine Devices; Myometrium; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2006 |
FDG-PET detected thyroid incidentalomas: need for further investigation?
Topics: Biopsy, Fine-Needle; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Population Surveillance; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18F-fluorodeoxyglucose-avid thyroid incidentalomas in patients with lymphoma.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2006 |
Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Ultrasonography | 2006 |
F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Preoperative evaluation of thyroid nodules with 18FDG-PET/CT or MIBI scan?
Topics: Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
The significance of FDG uptake in bilateral thyroid glands.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2007 |
A surgical perspective on positron emission tomography.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Vena Cava, Superior; Venous Thrombosis; Whole Body Imaging | 2007 |
FDG PET/CT for assessing therapy response in primary thyroid lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Whole Body Imaging | 2007 |
Uptake characteristics of FDG in multiple juvenile cellular fibroadenomata of the breast: FDG-PET and histopathologic correlation.
Topics: Adolescent; Breast Neoplasms; Diagnosis, Differential; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Hürthle cell thyroid carcinoma metastatic to the sigmoid colon.
Topics: Adenoma, Oxyphilic; Colon, Sigmoid; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
A case of Lhermitte-Duclos disease presenting high FDG uptake on FDG-PET/CT.
Topics: Adenoma; Aged; Cerebellum; Fluorodeoxyglucose F18; Hamartoma Syndrome, Multiple; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid.
Topics: Aged; Carcinoma, Mucoepidermoid; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Laryngeal giant cell tumor mimicking thyroid cancer demonstrated by PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Laryngeal Neoplasms; Leydig Cell Tumor; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Statistics, Nonparametric; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Thyroid Neoplasms | 2007 |
Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
Topics: Aged; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Parotid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2007 |
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Topics: Adenocarcinoma, Follicular; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2007 |
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2007 |
Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms | 2007 |
[Roles of single photo emission computed tomography-CT in detecting residual tumor from patients with thyroid carcinoma].
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2007 |
Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma.
Topics: Aged; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Middle Aged; Neoplasms, Second Primary; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Imaging in endocrinology: Langherans cell histiocytosis of the thyroid gland detected by 18FDG-PET/CT.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Thyrotropin | 2007 |
Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy | 2007 |
[Diagnostic value of positron emission tomography/computed tomography with fluorine-18 fluordeoxyglucose in patients with differentiated thyroid gland carcinoma, high thyroglobulin serum levels and negative iodine whole body scan].
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Japan; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Thyroid Gland; Thyroid Neoplasms; Tissue Distribution | 2007 |
F-18 FDG PET/CT in the management of thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, X-Ray Computed | 2007 |
Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
Topics: Adenoma, Oxyphilic; Carcinoma; Fluorodeoxyglucose F18; Humans; Incidence; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Whole Body Imaging | 2007 |
Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Topics: Calcitonin; Carcinoma, Medullary; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Topics: Decision Making; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Topics: Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases.
Topics: Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Osteosarcoma; Osteotomy; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2007 |
[Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET)].
Topics: Adenoma; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2007 |
Silent parathyroid adenoma mistakenly interpreted on FDG-PET as thyroid cancer metastasis in a patient with elevated thyroglobulin and negative I-131 whole body scan and removed by radioguided minimally invasive surgery.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Minimally Invasive Surgical Procedures; Parathyroid Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Whole Body Imaging | 2008 |
Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Thyroid Neoplasms; Thyroidectomy | 2008 |
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Topics: Adult; Aged; Biomarkers, Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Signal Processing, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2008 |
Follicular thyroid carcinoma metastasis to the esophagus detected by 18FDG PET/CT.
Topics: Adenocarcinoma, Follicular; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Detection of thyroid metastases from nasopharyngeal carcinoma with F-18 FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
[Annex V: 18-fluorodeoxyglucose positron emission tomography in the management of differentiated thyroid cancers].
Topics: Contraindications; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Pregnancy; Prognosis; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Detection of thyroid plasmacytoma by F-18 FDG PET/CT imaging.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2008 |
Huge thyroid uptake of 18F-FDG in a patient with Hashimoto's thyroiditis referred for a malignant thyroid lesion.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hashimoto Disease; Humans; Positron-Emission Tomography; Thyroid Gland; Thyroid Neoplasms; Ultrasonography | 2008 |
Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphy.
Topics: Bronchitis; Carcinoma, Medullary; Chronic Disease; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Thyroid Neoplasms | 2008 |
Metastatic follicular carcinoma of the thyroid with tumor thrombus in the superior vena cava and right brachiocephalic and internal jugular veins: FDG-PET/CT findings.
Topics: Adenocarcinoma, Follicular; Brachiocephalic Veins; Female; Fluorodeoxyglucose F18; Humans; Jugular Veins; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Vena Cava, Superior; Venous Thrombosis | 2008 |
Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Topics: Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neck; Sodium Iodide; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms; Tomography, Emission-Computed | 1995 |
[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Topics: Adenocarcinoma, Follicular; Biological Transport; Carcinoma, Papillary; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Prognosis; Thyroid Neoplasms; Tomography, Emission-Computed | 1995 |
Determination of malignancy of thyroid nodules with positron emission tomography.
Topics: Adenocarcinoma, Follicular; Adenoma; Adult; Aged; Body Weight; Carcinoma, Papillary; Deoxyglucose; Female; Fluorodeoxyglucose F18; Goiter, Nodular; Humans; Infant; Male; Middle Aged; Neoplasm Staging; Thyroid Neoplasms; Thyroid Nodule; Thyroidectomy; Tomography, Emission-Computed | 1993 |
Positron emission tomography of thyroid masses.
Topics: Adenoma; Adult; Aged; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Goiter; Humans; Male; Middle Aged; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 1993 |
Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Topics: Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 1993 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Thyroid Neoplasms; Tomography, Emission-Computed | 1996 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1996 |
F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity, Morbid; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1996 |
Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Radiography; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neck; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 1997 |
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thyroid Neoplasms | 1997 |
Early changes in fluorine-18-FDG uptake during radiotherapy.
Topics: Aged; Carcinoma, Papillary; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Blotting, Western; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms | 1997 |
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Topics: Adult; Aged; Algorithms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Therapy, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer.
Topics: Arthritis, Rheumatoid; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Joints; Lung; Lung Diseases; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Topics: Adenoma; Adult; Aged; Carcinoma, Papillary; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 1998 |
Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Radiopharmaceuticals; Technetium; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Case-Control Studies; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
[F-18-FDG PET in autonomous goiter].
Topics: Adenoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Goiter, Nodular; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Receptors, Thyrotropin; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1998 |
FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.
Topics: Adenoma, Oxyphilic; Aged; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy; Carcinoma, Papillary; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1999 |
Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
Topics: Adenocarcinoma, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thymus Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Role of FDG PET in metastatic thyroid cancer.
Topics: Autoantibodies; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Topics: Adult; Aged; Autoantibodies; Bone Neoplasms; Carcinoma, Papillary; Data Interpretation, Statistical; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Pregnancy testing before high-dose radioiodine treatment: a case report.
Topics: Adult; Carcinoma, Papillary; Female; Fetus; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Pregnancy; Pregnancy Tests; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Comparison of different tracers in the follow up of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
The detection of small carcinoma with 18F-FDG using a dual head coincidence camera.
Topics: Adult; Aged; Carcinoma, Papillary; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Male; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results.
Topics: Adult; Aged; Cell Differentiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue.
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Papillary; Delayed-Action Preparations; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PE.
Topics: Adenoma; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Goiter; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aftercare; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Patient Selection; Practice Guidelines as Topic; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2000 |
18F-FDG for the staging of patients with differentiated thyroid cancer: comparison of a dual-head coincidence gamma camera with dedicated PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2000 |
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2000 |
FDG PET in thyroid cancer: thyroxine or not?
Topics: Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2000 |
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.
Topics: Adult; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Hormones; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, Emission-Computed | 2001 |
Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, Emission-Computed | 2001 |
Clinical usefulness of FDG PET in differentiated thyroid cancer.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Radiopharmaceuticals; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Metastatic thyroid cancer occurring as an unknown primary lesion: the role of F-18 FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
[Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results].
Topics: Adult; Aged; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Laryngeal Neoplasms; Male; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
[Primary diagnosis of papillary thyroid carcinoma in the framework of staging of malignant melanoma with F-18 deoxyglucose using PET].
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Melanoma; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Brain Neoplasms; Carcinoma, Papillary; Databases as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Magnetic Resonance Imaging; MEDLINE; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study.
Topics: Adult; Aged; Blood Glucose; Brain; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypothyroidism; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Regional Blood Flow; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Tomography, Emission-Computed | 2001 |
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Topics: Adult; Aged; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Focal F-18 FDG uptake in a nontoxic autonomous thyroid nodule.
Topics: Adenoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Thallium Radioisotopes; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2002 |
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
Topics: Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancer.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Larynx; Magnetic Resonance Imaging; Muscles; Neoplasm Recurrence, Local; Thyroid Neoplasms; Tomography, Emission-Computed; Vocal Cords; Voice | 2002 |
Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adult; Aged; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
Topics: Adenoma; Aged; Carcinoma, Medullary; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibroma; Radiopharmaceuticals; Thyroid Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 2002 |
[Diagnosis of metastasis of malignant melanoma in the thyroid gland with f18-FDG PET scan].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Asymmetric FDG uptake in a lactating breast.
Topics: Adult; Breast; Breast Feeding; Female; Fluorodeoxyglucose F18; Humans; Lactation; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2002 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Post-surgical follow-up of differentiated thyroid carcinoma.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Thyroid Neoplasms | 1991 |
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Carcinoma, Bronchogenic; Combined Modality Therapy; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Rectal Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1991 |
18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
Topics: Adenoma; Adult; Aged; Carcinoma; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Ploidies; Radionuclide Imaging; Thyroid Neoplasms | 1988 |
Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radioisotopes; Radionuclide Imaging; Thyroid Neoplasms | 1987 |